<html xmlns="http://www.w3.org/1999/xhtml"> <head> <style type="text/css">
      	     		 
      	    a                          {background : #ffffff; }
      	    article                    {border-style : dotted; border-width : 2px; }
		 	
		 	div                        {background : #ffffcc;}
		 	div.abstract-title         {font-weight : bold ; font-size : 16pt;}
		 	div.ack                    {border-style : solid ; border-color : red; margin : 2em; }
		 	div.article-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.boxed-text             {margin : 5em; border-style : solid;}
		 	div.contrib-group          {margin : 1em; }
		 	div.fig                    {border-style : solid; border-width : 2px; margin : 2em; }
		 	div.funding                {font-weight : bold ; font-size : 16pt;}
		 	div.given-names            {font-style : italic;}
		 	div.intro                  {border-style : inset; margin : 5px;}
		 	div.introduction           {border-style : inset; margin : 5px;}
		 	div.journal-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.journal-title-group    {background : #ffeeee;}
		 	div.article-title          {font-weight : bold ; font-size : 18pt;}
		 	div.kwd                    {font-style : italic}
		 	div.meta-name              {font-weight : bold ; font-size : 16pt;}
		 	div.name                   {font-weight : bold;}
		 	div.alt-title              {font-style : italic; font-size : 12px;}
		 	
		 	div.sec                    {border : 2px; margin 5px; padding 2px;}
		 	div.title                  {font-family : courier; font-weight : bold;
		 	                            font-size : 16pt; margin : 5px;}
		 	
		 	div.materials_methods      {border-style : double; margin : 5px; }
		 	div.methods                {border-style : double; margin : 5px; }
		 	
		 	div.results                {border-style : solid; margin : 5px;}
		 	div.background             {border-style : dotted; margin : 5px;}
		 	
		 	div.discussion             {border-style : groove; margin : 5px;}
		 	div.conclusion             {border-style : ridge; margin : 5px;}
		 	div.conclusions             {border-style : ridge; margin : 5px;}
		 	div.supplementary-material {border-style : inset; margin : 5px;}
		 	div.abbreviations          {border-style : double; border-color : red; margin : 5px;}
		 	div.competinginterests     {border-style : double; border-color : blue; margin : 5px;}
		 	div.acknowledgements       {border-style : double; border-color : green; margin : 5px;}
		 	div.authors_contributions   {border-style : double; border-color : purple; margin : 5px;}
		 	
		 	div.publisher              {border-style : outset; margin : 5px;}
		 	div.fn-type-conflict       {background : #f88; }
		 	div.fn-type-con            {background : #ddf; }
		 	div.fn-type-other          {background : #ddd; }
		 	
		 	div.unknown                {background : #ffd;
									 	  border-style : solid;
									 	  border-width : 1px;
									 	  padding : 2 px;}
		 	  
      	    table                      {background : #ffffdd;}
		 	tr                         {background : #ddddff; padding : 1px;}
		 	
		 	span                       {background : #ffcccc;}
		 	
		 	span.citation-author       {font-family : helvetica; background : #ffeeee;}
		 	span.collab                {background : #ddffff; }
		 	span.comment               {font-family : courier; font-size : 6px; background : #ffaaff;}
		 	span.contrib               {background : #ffffff;}
		 	span.corresp               {background : #ddffdd; }
		 	span.doi                   {background : #ffffff;}
		 	span.email                 {font-family : courier; }
		 	span.etal                  {font-style : italic;}
		 	span.fpage                 {font-family : courier;}
		 	span.given-names           {background : #ffffff;}
		 	span.iso-abbrev            {background : #ffffff;}
		 	span.issn-epub             {background : #ffffff;}
		 	span.issn-ppub             {background : #ffffff;}
		 	span.journal-title         {background : #ffffff;}
		 	span.lpage                 {font-family : courier;}
		 	span.mixed-article-title   {font-style : italic ;}
		 	span.nlm-ta                {background : #ffffff;}
		 	span.pmc                   {background : #ffffff;}
		 	span.pmcid                 {background : #ffffff;}
		 	span.pmid                  {background : #ffffff;}
		 	span.publisher             {background : #ffffff;}
		 	span.publisher-id          {background : #ffffff;}
		 	span.publisher-name        {background : #ffffff;}
		 	span.source                {background : #ffffff;}
		 	span.subject               {background : #ffffff;}
		 	span.surname               {background : #ffffff;}
		 	span.volume                {font-family : courier; font-weight : bold;}
		 	span.year                  {font-family : courier ; font-style : italic;}
			</style> </head> <body> <div class="front" title="front"> <div class="journal-meta" tagx="journal-meta" title="journal-meta"><span class="nlm-ta" title="nlm-ta">J Enzyme Inhib Med Chem</span><span class="iso-abbrev" title="iso-abbrev">J Enzyme Inhib Med Chem</span><div class="journal-title-group" tagx="journal-title-group" title="journal-title-group"><span class="journal-title" tagx="journal-title" title="journal-title">Journal of Enzyme Inhibition and Medicinal Chemistry</span></div><span class="issn-ppub" tagx="issn" title="issn-ppub">1475-6366</span><span class="issn-epub" tagx="issn" title="issn-epub">1475-6374</span><div class="publisher" tagx="publisher" title="publisher"><span class="publisher-name" tagx="publisher-name" title="publisher-name">Taylor &amp;amp; Francis</span></div> </div> <div class="article-meta" tagx="article-meta" title="article-meta"><span class="pmcid" title="pmcid"> pmcid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/6896476">6896476</a></span><span class="pmid" title="pmid"> pmid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/31790602">31790602</a></span><span class="doi" title="doi"> doi: <a href="https://dx.doi.org/10.1080/14756366.2019.1698036">10.1080/14756366.2019.1698036</a></span><span class="publisher-id" title="publisher-id">1698036</span><div class="unknown" title="article-version" tag="article-version">
Version of Record</div> <div class="article-categories" title="article-categories">
: <span class="subject" title="subject">Review</span>: <span class="subject" title="subject">Review Article</span></div> <div class="title-group" tagx="title-group" title="title-group"> <div class="article-title" title="article-title">
Benzothiazole derivatives as anticancer agents</div> <div class="alt-title" title="alt-title">
A. Irfan et al.</div> </div> <div class="contrib-group" title="contrib-group"><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Irfan</span><span class="given-names" tagx="given-names" title="given-names">Ali</span></span><a href="#AF0001">a</a><a href="#AN0001" /></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Batool</span><span class="given-names" tagx="given-names" title="given-names">Fozia</span></span><a href="#AF0001">a</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zahra Naqvi</span><span class="given-names" tagx="given-names" title="given-names">Syeda Andleeb</span></span><a href="#AF0001">a</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Islam</span><span class="given-names" tagx="given-names" title="given-names">Amjad</span></span><a href="#AF0002">b</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Osman</span><span class="given-names" tagx="given-names" title="given-names">Sameh M.</span></span><a href="#AF0003">c</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nocentini</span><span class="given-names" tagx="given-names" title="given-names">Alessio</span></span><a href="#AF0004">d</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Alissa</span><span class="given-names" tagx="given-names" title="given-names">Siham A.</span></span><a href="#AF0005">e</a></span><span class="contrib" title="contrib"><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0003-4262-0323</span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Supuran</span><span class="given-names" tagx="given-names" title="given-names">Claudiu T.</span></span><a href="#AN0002" /><a href="#AF0004">d</a></span><span class="citation_author_institution" id="AF0001">[a], <span class="institution" title="institution">Department of Chemistry, University of Lahore</span><span class="city" tagx="city" title="city">Sargodha</span><span class="country" tagx="country" title="country">Pakistan</span></span><span class="citation_author_institution" id="AF0002">[b], <span class="institution" title="institution">College of Materials Engineering, Fujian Agriculture and Forestry University</span><span class="city" tagx="city" title="city">Fuzhou</span><span class="country" tagx="country" title="country">P.R. China</span></span><span class="citation_author_institution" id="AF0003">[c], <span class="institution" title="institution">Chemistry Department, College of Science, King Saud University</span><span class="city" tagx="city" title="city">Riyadh</span><span class="country" tagx="country" title="country">Saudi Arabia</span></span><span class="citation_author_institution" id="AF0004">[d], <span class="institution" title="institution">NEUROFARBA Department, Section of Pharmaceutical and Nutraceutical Sciences, University of Florence</span><span class="city" tagx="city" title="city">Sesto Fiorentino (Firenze)</span><span class="country" tagx="country" title="country">Italy</span></span><span class="citation_author_institution" id="AF0005">[e], <span class="institution" title="institution">Chemistry Department, College of Science, Princess Nourah bint Abdulrahman University</span><span class="city" tagx="city" title="city">Riyadh</span><span class="country" tagx="country" title="country">Saudi Arabia</span></span></div> <div class="author-notes" title="author-notes"> <div class="corresp" title="corresp"><b>CONTACT</b> Ali Irfan <span class="email" tagx="email" title="email">aliirfanrai@hotmail.com</span><span class="institution" title="institution">Department of Chemistry, University of Lahore</span>, <span class="addr-line" title="addr-line">Sargodha Campus</span>, <span class="city" tagx="city" title="city">Sargodha</span>, <span class="country" tagx="country" title="country">Pakistan</span>; </div> <div class="corresp" title="corresp">
Claudiu T. Supuran <span class="email" tagx="email" title="email">claudiu.supuran@unifi.it</span><span class="institution" title="institution">NEUROFARBA Department, Section of Pharmaceutical and Nutraceutical Sciences, University of Florence</span>, <span class="addr-line" title="addr-line">via Ugo Schiff 6</span>, <span class="postal-code" tagx="postal-code" title="postal-code">50019</span>, <span class="city" tagx="city" title="city">Sesto Fiorentino (Firenze)</span>, <span class="country" tagx="country" title="country">Italy</span></div> </div><span class="pub-date-" title="pub-date-">: <span>2019-12-12</span></span><span class="pub-date-" title="pub-date-">: <span>2020</span></span><span class="volume" tagx="volume" title="volume">35</span><span class="issue" tagx="issue" title="issue">1</span><span class="fpage" tagx="fpage" title="fpage">265</span><span class="lpage" tagx="lpage" title="lpage">279</span><div class="permissions"><span class="copyright" title="copyright">(C) <span class="copyright-holder" tagx="copyright-holder" title="copyright-holder">The Author(s)</span>, <span class="copyright-year" tagx="copyright-year" title="copyright-year">2019</span></span><span class="license" title="license"><span class="license-p" title="license-p">This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<a href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</span></span></div><a class="self-uri" href="IENZ_35_1698036.pdf" title="self-uri">IENZ_35_1698036.pdf</a><div class="abstract" title="abstract"> <div class="abstract-title" title="abstract-title">
Abstract</div> <div class="title" tagx="title" title="title">
Abstract</div> <p>Benzothiazole (BTA) belongs to the heterocyclic class of bicyclic compounds. BTA derivatives possesses broad spectrum biological activities such as anticancer, antioxidant, anti-inflammatory, anti-tumour, antiviral, antibacterial, anti-proliferative, anti-diabetic, anti-convulsant, analgesic, anti-tubercular, antimalarial, anti-leishmanial, anti-histaminic and anti-fungal among others. The BTA scaffolds showed a crucial role in the inhibition of the metalloenzyme carbonic anhydrase (CA). In this review an extensive literature survey over the last decade discloses the role of BTA derivatives mainly as anticancer agents. Such compounds are effective against various types of cancer cell lines through a multitude of mechanisms, some of which are poorly studied or understood. The inhibition of tumour associated CAs by BTA derivatives is on the other hand better investigated and such compounds may serve as anticancer leads for the development of agents effective against hypoxic tumours.</p> </div> <div class="kwd-group"> <div class="title" tagx="title" title="title">
Keywords</div> <div class="kwd" title="kwd">
Benzothiazole</div> <div class="kwd" title="kwd">
anticancer agent</div> <div class="kwd" title="kwd">
drug targets</div> <div class="kwd" title="kwd">
scaffold</div> <div class="kwd" title="kwd">
carbonic anhydrase inhibitor</div> </div> <div class="counts" title="counts"><span class="fig-count" title="fig-count">fig-count: </span><span class="table-count" title="table-count">table-count: </span><span class="page-count" title="page-count">page-count: </span><span class="word-count" title="word-count">word-count: </span></div> </div> </div> <div class="body" title="body"> <div class="introduction" title="sec"><span class="label" tagx="label" title="label">1.</span><div class="title" tagx="title" title="title">
Introduction</div> <p>Heterocyles are important pharmcophores and have significance to create privileged chemical structures possessing pharmacological activities. Five membered heterocyclic which incorporate oxygen, nitrogen and sulphur are found in broad spectrum therapeutic agents which have an enormous significance in drug discovery and drug development processes<a href="#CIT0001"><sup>1</sup></a>. Benzothaizole (BTA) is a fused benzoheterocyle which is present in many naturally occurring products and is responsible for the medicinal, pharmacological and pharmaceutical applications of such natural products<a href="#CIT0002"><sup>2</sup></a>. BTA is present in terrestrial as well as marine compounds which exhibit various biological activities<a href="#CIT0003"><sup>3</sup></a>. The BTA nucleus is formed by the fusion of the thiazole ring with a benzene ring<a href="#CIT0004"><sup>4</sup></a>.</p> <p>The pharmacological profile of the drug used for the management of amyotrophic lateral sclerosis Riluzole (<a href="#F0001">Figure 1</a>) attracted the attention of medicinal chemists towards biologically active benzothiazole<a href="#CIT0005"><sup>5</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 1.</span></a></div>   <p>Structure of riluzole, a drug for amyotrophic lateral sclerosis.</p>   </div> <p>The BTA scaffold possesses a wide spectrum of biological activities such as anti-inflammatory<a href="#CIT0006"><sup>6</sup></a>, fungicidal<a href="#CIT0007"><sup>7</sup></a>, anti-diabetic<a href="#CIT0008"><sup>8</sup></a>, analgesic<a href="#CIT0009"><sup>9</sup></a>, anti-microbial<a href="#CIT0010"><sup>10</sup></a>, antitumor<a href="#CIT0011"><sup>11</sup></a>, antileishmanial<a href="#CIT0012"><sup>12</sup></a>, antheltmintic<a href="#CIT0013"><sup>13</sup></a>, antirheumatic<a href="#CIT0014"><sup>14</sup></a> and CNS depressant<a href="#CIT0015"><sup>15</sup></a> etc. BTA derivatives exhibit remarkable and prevalent biological and pharmacological activities against different types of tumours and cancer cell lines such as HeLa (human cervical cancer cell line), SW480 (human colon adenocarcinoma cell line), HepG2 (human liver carcinoma cells)<a href="#CIT0016"><sup>16</sup></a>, mammary and ovarian tumour cell lines<a href="#CIT0017"><sup>17</sup></a>, colon, nonsmall-cell lung and breast subpanels cell lines<a href="#CIT0018"><sup>18</sup></a>, and HCC (hepatocellular carcinoma)<a href="#CIT0019"><sup>19</sup></a> etc.</p> <p>Cancer is the most prominent, notably complex and lethal disease which became a serious concern of todayâ€™s medical science. It poses a great challenge to medical scientific community for development of drugs, medicines and procedures for safer treatment and cure of cancer disease<a href="#CIT0020"><sup>20</sup></a>. These neoplasm tumour cells are diversified, heterogeneous cells with rapid proliferative properties. These neoplasm malignant tumours, have potential to invade or spread to other parts of body through blood stream and lymphatic system<a href="#CIT0021"><sup>21</sup></a>. The plethora of research mentioned in the present review of last decade on anticancer potential of BTA derivatives will be helpful in future drug discovery and drug development for the treatment of lethal cancer disease.</p> </div> <div class="btaderivativesasanticanceragents" title="sec"><span class="label" tagx="label" title="label">2.</span><div class="title" tagx="title" title="title">
BTA derivatives as anticancer agents</div> <div class="fluorinatedderivativesofbenzothiazoleasanticanceragents" title="sec"><span class="label" tagx="label" title="label">2.1.</span><div class="title" tagx="title" title="title">
Fluorinated derivatives of benzothiazole as anticancer agents</div> <p>Aiello etÂ al. synthesised fluorinated 2-aryl benzothiazole derivatives and evaluate them for anti-tumour activities against cancer cell lines such as MDA-MB-468 (mammary gland/breast tissues derived from metastatic site) and MCF-7 cell line (human breast adenocarcinoma). The fluorinated BTA derivatives <b>1</b> (3â€"(5-fluorobenzo[d]thiazol-2-yl)phenol) and <b>2</b> (4â€"(5-fluorobenzo[d]thiazol-2-yl)phenol) having hydroxyl substituents on the third and fourth position of phenyl exhibited the best activity having GI<sub>50</sub> values of 0.57 and 0.4â€‰ÂµM respectively against MCF-cell line as compared to BTA derivatives containing alkoxy, methyl sulphonyl and ethyl substituents on the benzothiazole (<a href="#F0002">Figure 2</a>). Kumbhare etÂ al. afforded the <i>N</i>-bis-benzothiazole and benzothiazolyl thiocarbamide derivatives and screened for cytotoxic activities against two human cell lines U-937 (human macrophage cell line), THP-1 (human leukaemia monocytic cell line) and B16-F10 (mouse melanoma cell line). The thiourea containing benzothiazole derivative <b>3</b> (<a href="#F0003">Figure 3</a>) demonstrated the best antiproliferative activity against the U-937 cell line as compared to standard drug Etoposide. The IC<sub>50</sub> values of compound <b>3</b> were higher (16.23â€‰Â±â€‰0.81â€‰ÂµM)), (4847.73â€‰Â±â€‰2.39â€‰ÂµM)) and (34.58â€‰Â±â€‰1.73â€‰ÂµM)) as compared to standard compound etoposide IC<sub>50</sub> values (17.94â€‰Â±â€‰0.89), (18.69â€‰Â±â€‰0.94) and (2.16â€‰Â±â€‰0.11â€‰ÂµM)) against U-937, B16-F10 and THP-1 cell lines respectively<a href="#CIT0022"><sup>22</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 2.</span></a></div>   <p>Substituted phenols containing a flourobenzothiazol scaffold <b>1</b> and <b>2</b>.</p>   </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 3.</span></a></div>   <p>Substituted thiourea containing benzothiazole derivative <b>3</b> and the <b>s</b>ubstituted pyrrolidine based imidazo benzothiazole derivative <b>4</b>.</p>   </div> <p>Kumbhare etÂ al. reported the synthesis of mannich base arylimidazo derivatives containing benzothiazole moiety and screened for their anticancer activities against HepG2, MCF -7 and HeLa cell lines. All these synthesised mannich bases BTA scaffolds showed cytotoxicity against all tested cell lines but the pyrrolidine based imidazo benzothiazole derivative <b>4</b> (<a href="#F0003">Figure 3</a>) demonstrated specific features of apoptosis as enhancement in the levels of caspase-3. The compound <b>4</b> exhibited anti cancer activity and proved to be the best antiproliferative agent as compared to other derivatives against HepG2, MCF-7 and HeLa cell line when screened at 4.0â€‰ÂµM concentrations. The SAR studies revealed that the incorporation of fluorine atom at the 7<sup>th</sup> position of derivative <b>4</b> enhanced the cytotoxicity. The compound <b>4</b> have potential to lead in the treatment of cancer especially against hepatocaricinoma. The anticancer activity potential of BTA scaffold <b>4</b> is encourging for the development of new anti-cancer therapeutic agents and this will be good addition in armamentarium that consists of paclitaxel, cisplatin and doxorubicin drugs<a href="#CIT0023"><sup>23</sup></a>.</p> <p>Caputo etÂ al. afforded two types of five derivatives on the basis of an aryl amide and an aryl urea functionalities attached at C-2 of benzothiazole core and these scaffolds were screened against 60 human cancer cell lines. The urea moiety based fluorophenyl containing benzothiazole derivative <b>4</b> (<a href="#F0003">Figure 3</a>) and cyanophenyl containing benzothiazole derivative <b>5</b> (<a href="#F0004">Figure 4</a>) demonstrated remarkable anticancer activities. The BTA derivative <b>4</b> exhibited the anticancer activity at 10<sup>âˆ’5â€‰</sup>M against different cell lines such as leukaemia cell lines (log GI<sub>50</sub> value âˆ’5.48), non-small cell lung cell lines (log GI<sub>50</sub> value âˆ’5.48), colon cancer cell lines (log GI<sub>50</sub> value âˆ’5.51), central nervous system cancer cell lines (log GI<sub>50</sub> value âˆ’5.49), melanoma cell lines (log GI<sub>50</sub> value âˆ’5.48), ovarian cancer cell lines (log GI<sub>50</sub> value âˆ’5.49), renal cancer cell lines (log GI<sub>50</sub> value âˆ’5.53), prostate cancer cell lines (log GI<sub>50</sub> value âˆ’5.50) and breast cancer cell lines (log GI<sub>50</sub> value âˆ’5.56) in comparison with reference drug 5-fluorouracil NSC 19893. The BTA scaffold <b>5</b> showed remarkable growth inhibitory activities against different human tumour cell lines such as leukaemia cell lines (log GI<sub>50</sub> value âˆ’5.93), non-small cell lung cell lines (log GI<sub>50</sub> value âˆ’6.0), colon cancer cell lines (log GI<sub>50</sub> value âˆ’5.89), central nervous system cancer cell lines (log GI<sub>50</sub> value âˆ’5.73), melanoma cell lines (log GI<sub>50</sub> value âˆ’5.89), ovarian cancer cell lines (log GI<sub>50</sub> value âˆ’5.74), renal cancer cell lines (log GI<sub>50</sub> value âˆ’5.90), prostate cancer cell lines (log GI<sub>50</sub> value âˆ’5.72) and breast cancer cell lines (log GI<sub>50</sub> value âˆ’6.0) as compared with reference drug 5-fluorouracil NSC 19893. The scaffolds <b>4</b> and <b>5</b> showed the best anticancer therapeutic potential due to presence of electron with drawing groups on <i>para</i> position of phenyl ring<a href="#CIT0023"><sup>23</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 4.</span></a></div>   <p>Substituted fluorophenyl containing benzothiazole urea derivative <b>5</b> and 2-substituted cyanophenyl containing benzothiazole urea derivatives <b>6</b>.</p>   </div> <p>El-Damasy etÂ al. synthesised the novel amide and urea based BTA series of 20 sorafenib analogues in which the pyridylamide privileged functionality was attached with an ether linkage at 6-position of the BTA ring. A selected group of 12 potent scaffolds were evaluated and appraised for anti-proliferative activities against sixty human cancer cell lines. These chlorotrifluoromethyl phenyl ureido picolinamide benzothiazoles <b>7</b> (<a href="#F0005">Figure 5</a>), bis-trifluoromethyl phenyl ureido based picolinamide benzothiazole derivative <b>8</b> (<a href="#F0005">Figure 5</a>) and dichlorophenyl ureido based picolinamide benzothiazoles <b>9</b> (<a href="#F0005">Figure 5</a>) were more potent in the treatment of renal cell carcinoma than the standard drug sorafenib, used for the treatment of such tumours. The 3,5-bis-trifluoromethylphenylurea <b>8</b> showed good inhibitory activities against ACHN (renal cancer cells lines) and A-498 (human kidney carcinoma cell line) with GI<sub>50</sub> values of 0.542â€‰ÂµM and 1.02â€‰ÂµM respectively. This compound also possess efficacy against UO-31 and RXF 393 cell lines. The derivatives <b>7</b> and <b>9</b> because of 3,4-disubstitutedphenyl moiety, exhibited excellent anti-proliferative activities with low IG<sub>50</sub> values of 1.85, 2.10â€‰ÂµM against RCC and ACHN cell lines respectively. The SAR study revealed the fact that sorafenib analogues possesses anti proliferative activity due to the presence of both urea spacer and phenyl disubstitution. Compound <b>8</b> demonstrated the highest CLogP value being the most lipophilic and potent derivative, in the low ÂµM range<a href="#CIT0024"><sup>24</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 5.</span></a></div>   <p>Derivative <b>7</b>â€"<b>9</b> discussed in the paper.</p>   </div> <p>Ma etÂ al. reported BTA derivatives containing an <i>ortho</i>-hydroxy-N-acyl hydrazone moiety for antiproliferative activities and procaspase-3 kinase activation activities against five different cell lines, namely MDA-MB-231 (human breast adenocarcinoma cell line), MNK-45 (gastric cancer cell line), NCI-H226 (human lung cancer cell line), HT-29 (human colorectal adenocarcinoma cell line) and SK-N-SH (neuroblastoma cell line). The substituted 2-hydroxybenzylidene containing semicarbazide <b>10</b> (<a href="#F0006">Figure 6</a>) showed inhibitory activities against all cell lines with IC<sub>50</sub> and EC<sub>50</sub> values ranging from 0.24 to 0.92â€‰ÂµM and 0.31â€‰ÂµM respectively. The SAR studies revealed the paharmacological activities of BTA scaffold <b>10</b> in <i>in-vitro</i> is due to introduction of phenyl and benzyloxyl substitutions<a href="#CIT0025"><sup>25</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 6.</span></a></div>   <p>Benzothiazoles <b>10</b> and <b>11</b>.</p>   </div> <p>Gabr etÂ al. obtained hydrazine derivatives by treating 2-amino-6-fluorobenzothiazole with hydrazine hydrate which was further treated with the suitable aldehydes to afford 27 different BTA Schiff base derivatives. These derivatives were screened for anti-tumour potential against Hela (cervical cancer) and COS-7 (kidney fibroblast cancer) cell lines. The hydrazine based benzothiazole <b>11</b> (<a href="#F0006">Figure 6</a>) exhibited IC<sub>50</sub> of 2.41â€‰ÂµM and 4.31â€‰ÂµM against Hela and COS-7 cell lines as compared to reference doxorubicin having IC<sub>50</sub> 2.05â€‰ÂµM and 3.04â€‰ÂµM respectively. The SAR studies explained the effect of various substitutions on activities of all the synthesised derivatives. The scaffold present in <b>11</b> has the 2â€"(4-hydroxy-methoxy benzylidene)-hydrazino moiety at the C-2 position which remarkably enhances the anti-tumour potential, whereas replacing the 4-hydroxy moiety with 4-methoxy decreased the activities against both cell lines<a href="#CIT0026"><sup>26</sup></a>.</p> <p>Junjie etÂ al. reported the synthesis of semicarbazone containing BTA derivatives by the reaction of 4-nitrobenzyl bromide with substituted amines under different reaction conditions and evaluated their anticancer activity against four different cancer cell line such as human colon cancer cells (HT29), human lung cancer cell (H460), non-small cell lung cancer (A549) and human breast cancer (MDA-MB-231). Among these derivatives, the indole based hydrazine carboxamide scaffold <b>12</b> (<a href="#F0007">Figure 7</a>) showed potent antitumor activity with IC<sub>50</sub> values of 0.015â€‰ÂµM for HT29, 0.28â€‰ÂµM for H460, 1.53â€‰ÂµM for A549 and 0.68â€‰ÂµM for MDA-MB-231. The structure â€" activity relationship explained that compound <b>12</b> exhibited the highest antitumor activity due to the presence of electron withdrawing groups in the 4 position of benzyl ring<a href="#CIT0027"><sup>27</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 7.</span></a></div>   <p>Indol based hydrazine carboxamide benzothiazole derivative <b>12</b>.</p>   </div> </div> <div class="imidazolebasedbenzothiazolederivativesasanticanceragents" title="sec"><span class="label" tagx="label" title="label">2.2.</span><div class="title" tagx="title" title="title">
Imidazole based benzothiazole derivatives as anticancer agents</div> <p>Yurttas etÂ al. obtained 2â€"(4-aminophenyl)BTA derivatives substituted with different heterocyclic rings and tested their antitumor potential against 60 human tumour cell lines. The BTA derivatives <b>13</b> (2â€"(1<i>H</i>-benzo[d]imidazol-2-ylthio)-<i>N</i>-(4-(benzo[d]thiazol-2-yl)-3-chlorophenyl) acetamide) (<a href="#F0008">Figure 8</a>) and <b>14</b> (<i>N</i>-(4-(benzo[d]thiazol-2-yl)phenyl)-2-(1-phenyl-1<i>H</i>-benzo[<i>d]</i>imidazol-2-yl-thio)-acetamide) (<a href="#F0008">Figure 8</a>) showed remarkable antitumor potential against different cancer cell lines. The heterocylic substitutions affect the activity and antitumor potential of these BTA derivatives, with derivative <b>14</b> having comparable antitumor potential with the standard drugs whereas derivative <b>13</b> being less active compared to <b>14</b>. The order overall antitumor potential of 2â€"(4-aminophenyl) benzothiazole derivatives with reference to the heterocyclic substitution was benzimidazole <span class="inline-formula" title="inline-formula"> </span></p><div class="alternatives" title="alternatives"><span class="inline-graphic" title="inline-graphic" /><div class="math_UNKNOWN"> <div class="mo_UNKNOWN">
â‰¥</div></div></div> imidazoleâ€‰&amp;gt;â€‰benzothiazoleâ€‰&amp;gt;â€‰benzoxazole<a href="#CIT0028"><sup>28</sup></a>.<p /> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 8.</span></a></div>   <p>Substituted phenyl imidazole based benzothiazoles <b>13</b> and <b>14</b>.</p>   </div> <p>Singh etÂ al. reported the synthesis of imidazole based benzothiazoles by treatment of substituted anilines with KSCN which afforded the desired benzothiazole derivatives, and studied their anticancer activities. Compound <b>15</b> (<a href="#F0009">Figure 9</a>) showed excellent anticancer activity possessing IC<sub>50</sub> value 10â€‰ÂµM when compared with the standard drug doxorubicin<a href="#CIT0029"><sup>29</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 9.</span></a></div>   <p>Imidazole based benzothiazole derivative <b>15</b>.</p>   </div> </div> <div class="piperazinebasedbenzothiazolederivativesasanticanceragents" title="sec"><span class="label" tagx="label" title="label">2.3.</span><div class="title" tagx="title" title="title">
Piperazine based benzothiazole derivatives as anticancer agents</div> <p>Al-Soud. etÂ al. reported the synthesis of BTA derivatives incorporating sulphonamide, piperazino-arylsulfonamide and arylthiol scaffolds and determined their anti-proliferative potential against different cell lines, such as CCRF-SB (Human acute B-lymphoblastic leukaemia), DU-145 (human prostate cancer cell lines express androgen receptor), HepG-2 cell line (human liver cancer), WIL-2NS (Human splenic B-lymphoblastoid cells), MRC-5 (human lung fibroblast cell line), MCF-7 cell line (human breast adenocarcinoma), MT-4 (human T-cells containing an integrated HTLV-1 genome), SK-MES-1 cell line (human lung cancer) and SK-28 cell line (skin melanoma). Derivative <b>16</b> (<i>N</i>-(2â€"(4-(benzo[d]thiazol-2-yl)piperazin-1-yl)-2-oxoethyl)-4-chloro-benzenesulfonodithioamide) showed antiproliferative activity (CC<sub>50</sub> = 8â€‰Â±â€‰3â€‰ÂµM) against human derived DU-145 cell line (<a href="#F0010">Figure 10</a>) whereas derivative <b>17</b> (<i>N</i>-(2â€"(4-(benzo[d]thiazol-2-yl) piperazin-1-yl)-2-oxoethyl)-2,5-dichloro benzenesulfonodithio-amide) demonstrated remarkable activities against several human derived cell lines such as HepG2 and DU-145 (with CC<sub>50</sub> of 8â€‰Â±â€‰2â€‰ÂµM, and 9â€‰Â±â€‰2â€‰ÂµM, respectively) (<a href="#F0010">Figure 10</a>). Derivatives <b>16</b> and <b>17</b> exhibited atiproliferative potential due to the introduction of chloro and dichloro phenyl groups while their replacement of with hydrogen, methoxy, nitro, triflouromethyl and methyl groups lead to a decrease in the antiproliferative potential of BTA derivatives<a href="#CIT0030"><sup>30</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 10.</span></a></div>   <p>Di-/monochlorobenzenesulfonamide based piperazine benzothiazoles derivative <b>16</b> and <b>17</b>.</p>   </div> <p>Gurdal etÂ al. synthesised BTA derivatives which incorporate piperazine moieties and evaluated their cytotoxicity against different cancer cell lines such as HUH-7 (Heptacellular), MCF-7 (Breast) and HCT-116 (Colorectal). GI<sub>50</sub> values of these derivatives indicated that all compounds exhibited good potential against the aforementioned cell lines but the pyridine containing derivative <b>18</b> (<a href="#F0011">Figure 11</a>) had a remarkable cytotoxic activity with GI<sub>50</sub> value 7.9â€‰ÂµM, 9.2â€‰ÂµM and 3.1â€‰ÂµM for HCT-116, MCF-7 and HUH-7 respectively. Apoptosis caused by this derivative during cell cycle arrest at subG1 phase was confirmed by Hoechst staining and fluorescence activated cell sorting analysis<a href="#CIT0031"><sup>31</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 11.</span></a></div>   <p>Pyridine conataining piperazine benzothiazole derivative <b>18</b>.</p>   </div> </div> <div class="oxadiazolebasedbenzothiazolederivativesasanticanceragents" title="sec"><span class="label" tagx="label" title="label">2.4.</span><div class="title" tagx="title" title="title">
Oxadiazole based benzothiazole derivatives as anticancer agents</div> <p>Akhtar etÂ al. synthesised BTA and 1,3,4-oxadiazole-2-thione derivatives and determined their antitumor potential in <i>in-vitro</i> against different tumour cell lines. BTA derivatives <b>19</b> (N-(benzo[d]thiazol-2-yl)-2â€"(5-(1â€"(2-chlorophenoxy)propyl)-1,3,4-oxadiazol-2-ylthio)acetamide) and <b>20</b> (N-(benzo[d]thiazol-2-yl)-2â€"(5-(1â€"(3,4-dichlorophenoxy)ethyl)-1,3,4-oxadiazol-2-ylthio) acetamide) exhibited remarkable activities against CCRF-CEM (leukaemia) cell lines. The CC<sub>50</sub> values of compounds <b>19</b> and <b>20</b> (CC<sub>50</sub> = 12â€‰<span class="inline-formula" title="inline-formula"> </span></p><div class="alternatives" title="alternatives"><span class="inline-graphic" title="inline-graphic" /><div class="math_UNKNOWN"> <div class="mo_UNKNOWN">
Â±</div></div></div>â€‰2â€‰ÂµM and 8â€‰<span class="inline-formula" title="inline-formula"> <div class="alternatives" title="alternatives"><span class="inline-graphic" title="inline-graphic" /><div class="math_UNKNOWN"> <div class="mo_UNKNOWN">
Â±</div></div></div></span>â€‰1â€‰ÂµM respectively) were comparable to the standard drug Doxorubicin. The replacement of the chloro moiety with bromo in the hybrid structures of <b>19</b> and <b>20</b> decreased their anti-tumour potential (<a href="#F0012">Figure 12</a>)<a href="#CIT0032"><sup>32</sup></a>.<p /> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 12.</span></a></div>   <p>Oxadiazole based acetamide benzothiazole derivatives <b>19</b> and <b>20</b>.</p>   </div> </div> <div class="morpholine-thioureabasedbenzothiazolederivativesasanticanceragents" title="sec"><span class="label" tagx="label" title="label">2.5.</span><div class="title" tagx="title" title="title">
Morpholine-thiourea based benzothiazole derivatives as anticancer agents</div> <p>Saeed etÂ al. reported the synthesis of benzothiazole moiety based thiourea derivatives. These novel derivatives were tested for anticancer potential against cancer cell lines MCF-7 and HeLa cells. The MTT assay (colorimetric assessment of cell metabolic activity) indicated that the thiophene based acetamide benzothiazole derivatives <b>21</b> (<a href="#F0013">Figure 13</a>), morpholine based thiourea aminobenzothiazole derivative <b>22</b> (<a href="#F0013">Figure 13</a>) and morpholine based thiourea bromobenzothiazole <b>23</b> (<a href="#F0013">Figures 13</a>) were potent anticancer agents having IC<sub>50</sub> values of 24.15, 26.43 and 18.10â€‰ÂµM against MCF-7 cell line, and of 46.46, 45.29 and 38.85â€‰ÂµM against HeLa cells lines respectively<a href="#CIT0033"><sup>33</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 13.</span></a></div>   <p>Morpholine based thiourea bromobenzothiazoles <b>22â€"24</b>.</p>   </div> <p>Lei etÂ al. obtained the morpholine based acetamide benzothiazole derivative <b>24</b> (<a href="#F0014">Figure 14</a>) by the treatment of morpholine with 2-chloroacetyl chloride and studied its anticancer activity against HCC (human hepatocellular carcinoma) cell lines HepG2 and Bel7402, reporting IC<sub>50</sub> value for HepG2 and Bel7402 in the millimolar range<a href="#CIT0034"><sup>34</sup></a>.<sup>.</sup></p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 14.</span></a></div>   <p>Morpholine based acetamide benzothiazole <b>24</b>.</p>   </div> </div> <div class="thiophenebasedbenzothiazolederivativesasanticanceragents" title="sec"><span class="label" tagx="label" title="label">2.6.</span><div class="title" tagx="title" title="title">
Thiophene based benzothiazole derivatives as anticancer agents</div> <p>Racane etÂ al. obtained the furyl and thienyl based diamidino substituted derivatives of phenyl-BTA and screened them for antiproliferative activities against different tumour cell line <i>inÂ vitro</i>. Derivative <b>25</b> (diamidino-substituted thiophene based BTA, <a href="#F0015">Figure 15</a>) and <b>26</b> (imidazolinyl-substituted thiophene based BTA; <a href="#F0015">Figure 15</a>) exhibited low cytotoxic effects on normal human fibroblasts and strong antiproliferative effects on MiaPaCa-2 and MCF-7 cancer cell lines. The experimental data indicated that the benzothiazole derivatives having thiophene and imidazole substitions possessed interesting antiproliferative activities<a href="#CIT0035"><sup>35</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 15.</span></a></div>   <p>Imidazolinyl-substituted thiophene-based benzohiazoles <b>25</b> and <b>26</b>.</p>   </div> </div> <div class="thiadiazolebasedbenzothiazolederivativesasanticanceragents" title="sec"><span class="label" tagx="label" title="label">2.7.</span><div class="title" tagx="title" title="title">
Thiadiazole based benzothiazole derivatives as anticancer agents</div> <p>Sekar etÂ al. reported the synthesis and anticancer activities of six noval BTA derivatives. All derivatives exhibited anticancer activities from a high to a moderate activity level with the substituted thiadiazole flourobenzothiazole <b>27</b> (<a href="#F0016">Figure 16</a>) and methoxybenzothiazole <b>28</b> (<a href="#F0016">Figure 16</a>) showing the best anti-cancer potential due to the presence of highly electronative and electron denoting pharmacophores (e.g. fluorine and methoxy moieties)<a href="#CIT0036"><sup>36</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 16.</span></a></div>   <p>Substituted thiadiazole based BTAs <b>27</b> and <b>28</b>.</p>   </div> </div> <div class="substitutedpyridinebasedbenzothiazolederivativesasanticanceragents" title="sec"><span class="label" tagx="label" title="label">2.8.</span><div class="title" tagx="title" title="title">
Substituted pyridine based benzothiazole derivatives as anticancer agents</div> <p>Shi etÂ al. synthesised 20 BTA-2-thiol derivatives and investigated their anti-tumour potential against different cell lines such as SW480 (colon adenocarcinoma), HeLa, A549, HCT-116, HepG2 and SKRB-3 breast cancer cell line. The substituted bromopyridine acetamide benzothiazole derivative <b>29</b> (<a href="#F0017">Figure 17</a>) showed potent antitumor activity against SKRB-3, SW620, A549 and HepG2 cell lines with IC<sub>50</sub> values of 1.2â€‰nM, 4.3â€‰nM, 44â€‰nM and 48â€‰nM, respectively. Apoptosis was the mechanism of cell death and was concentration dependent in HepaG2 cells. These results indicated that BTA-2-thiols exhibit broad spectrum anti-cancer activities which are worth to be further investigated<a href="#CIT0016"><sup>16</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 17.</span></a></div>   <p>Substituted bromopyridine based acetamide benzothiazole derivative <b>29</b>.</p>   </div> <p>Xuejiao etÂ al. reported the synthesis of a substituted pyridine based acetamide BTA derivative <b>30</b> (<a href="#F0018">Figure 18</a>) and screened its anti-cancer activity both <i>inÂ vitro</i> and <i>in</i> v<i>ivo.</i> Derivative <b>30</b> demonstrated anti-proliferative activities against a wide spectrum of human cell lines and induced the mitochondrial apoptotic pathway in HepaG2 cell lines. The BTA scaffold <b>30</b> proved to be a promising candidate for cancer chemotherapy<a href="#CIT0037"><sup>37</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 18.</span></a></div>   <p>Substituted pyridine based acetamide benzothiazole <b>30</b> and pyridine containing pyrimidine benzothiazole <b>31</b>.</p>   </div> <p>Kamal etÂ al. reported the synthesis of novel phenyl pyridopyrimidinones based BTA derivatives which were examined against four different cancer cell lines such as ME-180, DU-145, MCF-7 and B-16. The pyridine containing pyrimidine benzothiazole <b>31</b> (<a href="#F0018">Figure 18</a>) exhibited interesting cytotoxicity with IC<sub>50</sub> value of 4.01â€‰ÂµM against ME-180 (human cervical cancer cell line)<a href="#CIT0038"><sup>38</sup></a>.</p> </div> <div class="pyrazolebasedbenzothiazolederivativesasanticanceragents" title="sec"><span class="label" tagx="label" title="label">2.9.</span><div class="title" tagx="title" title="title">
Pyrazole based benzothiazole derivatives as anticancer agents</div> <p>Gabr etÂ al. reported the synthesis and evaluation of novel BTA scaffolds against 60 tumour cell lines at a single dose of 10â€‰ÂµM. The best derivatives were <b>32</b> (<a href="#F0019">Figure 19</a>) and <b>33</b> (<a href="#F0019">Figure 19</a>), which were further screened at 5 doses. These derivatives demonstrated interesting anticancer activity at micro molar and sub micro molar concentrations, against all sixty tumour cell lines with GI<sub>50</sub> in the low micro molar or submicromolar range. The SAR study revealed that introduction of the pyrazole moiety significantly enhanced the antitumor activity of both derivatives. Furthermore the presence of 2-hydroxy ester and 3-oxopyrazole within the pyrimidine moiety increased the anti-tumour activities of both derivatives. The simple BTA scafolds having pyrazole functionalities were more potent against different cell lines as compared to derivatives having the pyrazole ring within a pyrimidine moiety<a href="#CIT0039"><sup>39</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 19.</span></a></div>   <p>Pyrazole based benzothiazoles <b>32</b> and <b>33</b>.</p>   </div> </div> <div class="pyrimidinebasedbenzothiazolederivativesasanticanceragents" title="sec"><span class="label" tagx="label" title="label">2.10.</span><div class="title" tagx="title" title="title">
Pyrimidine based benzothiazole derivatives as anticancer agents</div> <p>Kambhare etÂ al. synthesised the isoxazole pyrimidine based BTAs and evaluated them for anticancer activity by the MTT assay against different cell lines such as A549, Colo205, MCF-7 and U937 cell lines, in comparison with the standard drug etoposide. The pyridine containing pyrimidine derivative <b>34</b> (<a href="#F0020">Figure 20</a>) demonstrated good anti-cancer potential with IC<sub>50</sub> value 5.04â€‰ÂµM against colo205, 13.9â€‰ÂµM against U937, 30.67â€‰ÂµM against MCF-7 and 30.45â€‰ÂµM against A549 cell lines when compared with standard drug etoposide. The scaffold <b>34</b> activated p53 or TP53 (tumour protein) pathways, which regulate the equilibrium between apoptosis and cell proliferation. The SAR explained that the maximum cytotoxicity of derivative <b>34</b> against colon cancer cell line was due to the presence of methoxy group (â€"OCH<sub>3</sub>) in the phenyl<a href="#CIT0040"><sup>40</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 20.</span></a></div>   <p>Structure of pyrimidine based isoxazole derivative <b>34</b>.</p>   </div> <p>Waghmare etÂ al. reported the synthesis of substituted pyrimidine containing benzothiazole derivative <b>35</b> (<a href="#F0021">Figure 21</a>) by refluxing BTAs with bis-methylthio methylene malononitrile, and tested their anticancer activity against 18 different cell lines. The scaffold <b>35</b> possessed excellent anticancer activity with a good percentage of growth inhibition against lung cancer, breast cancer and renal cancer cell lines. The good anticancer activity of derivative <b>35</b> is due to the presence of two methyl and one SCH<sub>3</sub> groups in its structure<a href="#CIT0041"><sup>41</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 21.</span></a></div>   <p>Pyrimidine based benzothiazole derivative <b>35</b> and <b>36</b>.</p>   </div> <p>Caleta etÂ al. synthesised cyano and amidinobenzothiazole substituted anilins which were treated with 2-bromo-6-cyanobenzothiazole under specific reaction conditions to afford compounds which have been studied for their anticancer activity against 6 cancer cell lines such as laryngeal carcinoma (Hep-2), breast carcinoma (MCF-7), cervical carcinoma (HeLa), pancreatic carcinoma (MiaPaCa-2), colon carcinoma (SW 620), lung carcinoma (H 460), and diploid fibroblasts (WI 38). Among them, the pyrimidine based carbonitrile benzothiazole derivative <b>36</b> (<a href="#F0021">Figure 21</a>) showed potent activity against all cancer cell lines used in the study<a href="#CIT0042"><sup>42</sup></a>.</p> </div> <div class="piperidinebasedbenzothiazolederivativesasanticanceragents" title="sec"><span class="label" tagx="label" title="label">2.11.</span><div class="title" tagx="title" title="title">
Piperidine based benzothiazole derivatives as anticancer agents</div> <p>Osmaniye etÂ al. prepared BTA acylhydrazone using 4-fluorobenzaldehyde refluxed with substituted amines, to afford the desired derivatives and studied their anticancer activities against rat brain glioma (carcinogenic C6) cell line, human lung adenocarcinoma epithelial (A549) cell line, human breast adenocarcinoma (MCF-7) cell line, human colorectal adenocarcinoma (HT-29) cell line and mouse embryo fibroblast (NIH3T3) cell line. The piperidine based acetohydrazide derivative <b>37</b> (<a href="#F0022">Figure 22</a>) showed modest activity having IC<sub>50</sub> value 1â€‰<div class="â€‰mm,_UNKNOWN" href="#CIT0043"><sup>43</sup>.</div></p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 22.</span></a></div>   <p>Piperidine based acetohydrazide benzothiazole <b>37</b>.</p>   </div> </div> <div class="secondarysulphonamidebenzothiazolederivativesasanticanceragents" title="sec"><span class="label" tagx="label" title="label">2.12.</span><div class="title" tagx="title" title="title">
Secondary sulphonamide benzothiazole derivatives as anticancer agents</div> <p>Lad etÂ al. reported the synthesis of a series of methylsulfonyl benzothiazoles, obtained from 5-ethoxybenzothiazol-2-amine which were tested their anticancer activities. Among these derivatives, the nitrophenyl sulphonamide based methylsulfonyl benzothiazole <b>38</b> (<a href="#F0023">Figure 23</a>) and <i>ter</i>-butyl sulphonamide based methylsulfonyl benzothiazole <b>39</b> (<a href="#F0023">Figure 23</a>) exhibited the best anticancer activities against HeLa cell line with the IG<sub>50</sub> value of 0.22â€‰ÂµM and 0.6â€‰ÂµM respectively<a href="#CIT0044"><sup>44</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 23.</span></a></div>   <p>Sulphonamide based methylsulfonyl benzothiazoles <b>38</b> and <b>39</b>.</p>   </div> <p>Sadhasivam etÂ al. reported the synthesis of 2, 6-disubstituted-BTA by reaction of 2-amino-6-nitrobenzothiazole and acetic anhydride and studied their anticancer activity against three cancer cell lines MCF-7, HeLa and MG63 (human osteosarcoma) The sulphonamide scaffold based BTA <b>40</b> (<a href="#F0024">Figure 24</a>) exhibited modest anti-cancer activity with IC<sub>50</sub> of 34.5â€‰ÂµM for MCF-7, 44.15â€‰ÂµM for HeLa and 36.1â€‰ÂµM for the MG63<a href="#CIT0045"><sup>45</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 24.</span></a></div>   <p>Secondary sulphonamide based acetamide benzothiazole <b>40</b>.</p>   </div> </div> <div class="benzamidebasedbenzothiazolederivativesasanticanceragents" title="sec"><span class="label" tagx="label" title="label">2.13.</span><div class="title" tagx="title" title="title">
Benzamide based benzothiazole derivatives as anticancer agents</div> <p>Wang etÂ al. synthesised and evaluated 24 benzothiazole-2-thiol derivatives for antiproliferative activities against different human cancer cell lines such as A549, HCT-116, SW620, SW480, MDA-MB-468, SKRB-3, HeLa, SKOV-3, PC-3, BxPC-3, A431 and A375. Some derivatives exhibited better anticancer activities as compared to the standard drug cisplatin. The substituted methoxybenzamide benzothiazole <b>41</b> and the substituted chloromethylbenzamide benzothiazole <b>42</b> (<a href="#F0025">Figure 25</a>) showed good anti-tumour potential <i>inÂ vitro</i>, with IC<sub>50</sub> values ranging from 1.1â€‰ÂµM to 8.8â€‰ÂµM. The introduction of chloromethyl and methoxy functionalities in compounds <b>41</b> and <b>42</b> increased their anticancer activity compared to other synthesised analogs<a href="#CIT0046"><sup>46</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 25.</span></a></div>   <p>Substituted methoxybenzamide based benzothiazole derivative <b>41</b> and chloromethylbenzamide based benzothiazole <b>42</b>.</p>   </div> <p>Bolelli etÂ al. synthesised 2-substituted benzothiazoles by the reaction of carboxylic acid with thionyl chloride which afforded acyl chlorides, further treated with substituted benzothiazole to give 2-substituted benzothiazoles, which were studied for their inhibitory activities against human glutathione transferases (hGSTP1-1). The benzamide benzothiazole derivative <b>43</b> and benzamide methylbenzothiazole <b>44</b> (<a href="#F0026">Figure 26</a>) showed potent hGSTP1-1 inhibitory activities, useful in cancer chemotherapy. The SAR studies pinpointed that both these scaffold showed effective inhibition due to the presence of <i>para</i>-substitutions on the phenyl ring of the benzamide group<a href="#CIT0047"><sup>47</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 26.</span></a></div>   <p>Benzamide containing benzothiazoles <b>43</b> and <b>44</b>.</p>   </div> <p>Corbo etÂ al. reported 19 derivatives of benzamide based BTAs by the reaction of substituted aniline, potassium thiocyante and bromine, which afforded substituted compounds which were tested for anti-proliferative activity against MCF-7 and HepG2 cell lines. The substituted diflourobenzamide containing benzothiazole <b>45</b> (<a href="#F0027">Figure 27</a>) proved to be a potent anti-proliferative compound with the percentual inhibition of 64â€‰Â±â€‰2 ÂµM for MCF-7 cell line and of 64â€‰Â±â€‰6 ÂµM for HepG2 cell line<a href="#CIT0048"><sup>48</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 27.</span></a></div>   <p>Substituted difluorobenzamide BTA derivative <b>45</b>.</p>   </div> </div> <div class="quinolonebasedbenzothiazolederivatives" title="sec"><span class="label" tagx="label" title="label">2.14.</span><div class="title" tagx="title" title="title">
Quinolone based benzothiazole derivatives</div> <p>Abdelgawad etÂ al. synthesised quinolone based benzothiazole derivatives by the treatment of substituted benzothiazoles with aromatic aldehydes. The nitrobenzylidene containing quinolone derivative <b>46</b> (<a href="#F0028">Figure 28</a>) and the hydroxybenzylidine containing derivative <b>47</b> (<a href="#F0028">Figure 28</a>) showed antitumor activities against the MCF-7 cell line, having IC<sub>50</sub> values of 0.058â€‰ÂµM and 0.052â€‰ÂµM, respectively<a href="#CIT0049"><sup>49</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 28.</span></a></div>   <p>Hydroxybenzylidine containing quinolone benzothiazole derivative <b>46</b> and <b>the</b> nitrobenzylidene quinolone derivative <b>47</b>.</p>   </div> <p>Sarkar etÂ al. prepared benzothiazolyl quinoline derivatives by treatment of 2-aminobenzothiol with 2-hydroxy-benzaldehyde and studied their activities for the A1, A2A, A2B and A3 adenosine receptors. The A3 receptor is overexpressed in different cancer cell lines. The quinolone based derivative <b>48</b> (<a href="#F0029">Figure 29</a>) showed the maximum potency for the hA3 adenosine receptor<a href="#CIT0050"><sup>50</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 29.</span></a></div>   <p>Quinolone based benzothiazole derivative <b>48</b>.</p>   </div> </div> <div class="miscellaneousbenzothiazolederivativesasanticanceragents" title="sec"><span class="label" tagx="label" title="label">2.15.</span><div class="title" tagx="title" title="title">
Miscellaneous benzothiazole derivatives as anticancer agents</div> <p>Tay etÂ al. synthesised and evaluated <i>N</i>-[4-(benzothiazole-2yl) phenyl]-2-aryloxyacetamide derivatives for cytotoxicity and anticancer activity against sixty human cancer cell lines derived from 9 neoplastic diseases, among which L (leukaemia), M (melanoma), RC (renal cancer) NSCLC (non-small cell lung cancer) CC (colon cancer), OC (ovar ian cancer), BC (breast cancer), CNSC (central nervous system cancer) and PC (prostate cancer). Derivatives <b>49</b> (<i>N</i>-(4-(benzo[d]thiazol-2-yl)-3-methoxyphenyl)-3â€"(4-chlorophenyl)propanamide) and <b>50</b> (<i>N</i>-(4-(benzo[d]thiazol-2-yl)-2-chlorophenyl)-2â€"(4-chlorophenylthio)acetamide) (<a href="#F0030">Figure 30</a>) exhibited interesting anti-cancer activities. The SAR studies investigated that anticancer activities of these compounds were due to the substitutions (methoxy and chloro groups) present in their molecules<a href="#CIT0051"><sup>51</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 30.</span></a></div>   <p>Substituted propanamide/acetamide based benzothiazoles <b>49</b> and <b>50</b>.</p>   </div> <p>Noolvi etÂ al. reported the synthesis of chloro substituted benzothiazole amines in order to produce isothiocyanates and thioureases. These BTA derivatives were tested for their anticancer activities. The dichlorophenyl containing chlorobenzothiazole <b>51</b> (<a href="#F0031">Figure 31</a>) showed good anticancer activity against 9 different cancer cell lines having GI<sub>50</sub> values in the range of 1.60â€‰ÂµMâ€"71.8â€‰nM. The derivative <b>51</b> exhibited GI<sub>50</sub> = 7.18â€‰Ã—â€‰10<sup>âˆ’8â€‰</sup>M against non-small cell lung cancer (HOP-92). The SAR studies showed that the highest activity of compound <b>51</b> was due to the presence of three chlorine atoms in the compound as compared to other derivatives<a href="#CIT0052"><sup>52</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 31.</span></a></div>   <p>Dichlorophenyl-chlorobenzothiazole derivative <b>51</b>.</p>   </div> <p>Havrylyuk etÂ al. screened novel 4-thiazolidinone benzothiazole derivatives against ovarian, renal, prostate, leukaemia, melanoma, lung, colon, CNS and breast cancer cell lines. The thioxothiazolidine acetamide benzothiazole <b>52</b> (<a href="#F0032">Figure 32</a>) showed the most promising anti-cancer activity. The SAR studies pinpointed that the introduction of 4-chloro-phenoxy-<i>N</i>-(4-methoxyphenyl)-acetamide substitutions on position 5 of the 4-thiazolidinones ring enhanced the anti-cancer potential<a href="#CIT0053"><sup>53</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 32.</span></a></div>   <p>Substituted thioxothiazolidine acetamide benzothiazole derivative <b>52</b>.</p>   </div> <p>Prabhu etÂ al. synthesised and studied the anticancer activities of oxothiazolidine based BTA derivatives. The substituted chlorophenyl oxothiazolidine based benzothiazole <b>53</b> (<a href="#F0033">Figure 33</a>) showed the most effective anticancer activity against HeLa cell line, inducing 96.8% inhibition and IC<sub>50</sub> value of 9.76â€‰ÂµM, when compared with the reference drug cisplatin<a href="#CIT0054"><sup>54</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 33.</span></a></div>   <p>Oxothiazolidine based benzothiazole derivative <b>53</b> and thiazolidine benzothiazole derivative <b>54</b>.</p>   </div> <p>Abdelgawad etÂ al. synthesised thiazolidinone containing benzoxazole derivatives by the treatment of aminobenzoic acid with substituted aniline that further reacted in different steps under specific conditions to afford final product and studied their anticancer activities against breast cancer (MCF7) and liver cancer (HEPG2) cell lines. Among all these derivatives, nitrobenzylidene containing thiazolidine derivative <b>54</b> (<a href="#F0033">Figure 33</a>) exhibited some anticancer activity, with an IC<sub>50</sub> value of 36â€‰nM and 48â€‰nM against MCF7 and HEPG2, respectively<a href="#CIT0055"><sup>55</sup></a>.</p> <p>Ma etÂ al. reported indole based BTA derivatives and studied their anticancer activities. Among all these derivatives, the chlorobenzyl indole semicarbazide benzothiazole <b>55</b> (<a href="#F0034">Figure 34</a>) exhibited anticancer activity against four cancer cell lines such as HT-29, H460, A549 and MDA-MB-231. Derivative <b>55</b> showed IC<sub>50</sub> values of 0.024â€‰ÂµM for HT-29, 0.29â€‰ÂµM for H460, 0.84â€‰ÂµM for A549 and 0.88â€‰ÂµM for MDA-MB-231, respectively<a href="#CIT0056"><sup>56</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 34.</span></a></div>   <p>Chlorobenzyl indole semicarbazide BTA derivative <b>55</b> and urea BTA derivative <b>56</b>.</p>   </div> <p>Xie etÂ al. prepared substituted BTA derivatives and studied their anticancer activities. Among all derivatives, the urea benzothiazole <b>56</b> (<a href="#F0034">Figure 34</a>) exhibited interesting antitumor activity against 60 cancer cell lines. The average GI<sub>50</sub> value for derivative <b>56</b> was 0.38â€‰ÂµM<a href="#CIT0057"><sup>57</sup></a>.</p> <p>Uremis etÂ al. synthesised BTA derivatives using substituted aldehyde with bicyclo[3.2.0]hept-2-en-6-one. The nitro-styryl containing benzothiazole derivative <b>57</b> and the fluorostyryl benzothiazole derivative <b>58</b> (<a href="#F0035">Figure 35</a>) were reported for their anticancer activity against pancreatic cancer cells having IC<sub>50</sub> values of 27â€‰Â±â€‰0.24â€‰ÂµM for <b>57</b> and of 35â€‰Â±â€‰0.51â€‰ÂµM for derivative <b>58</b><a href="#CIT0058"><sup>58</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 35.</span></a></div>   <p>Nitrostyryl containing BTA derivative <b>57</b> and fluorostyryl BTA derivative <b>58</b>.</p>   </div> <p>Cindric etÂ al. obtained carboxamide containing benzothiazole by the condensation of substituted thiophenes and substituted amino-BTAs to prepare the desired product and studied their anticancer activity against MCF-7 cell line. The benzothiophene based carboxamide chloroaminobenzothiazole <b>59</b> (<a href="#F0036">Figure 36</a>) exhibited potent anticancer activity with an IC<sub>50</sub> of 40â€‰nM<a href="#CIT0059"><sup>59</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 36.</span></a></div>   <p>Benzothiophene carboxamide chloroaminobenzothiazole derivative <b>59</b>.</p>   </div> <p>Nikolova etÂ al. obtained Ru(III) complexes containing benzothiazole derivatives and tested their anticancer activity against K-562 and KE-37 (human leukemic) cell lines. Among all these derivatives, the Ru(III) containing methylbenzothiazole <b>60</b> (<a href="#F0037">Figure 37</a>) exhibited the highest cytotoxic activity against K-562 and KE-37, having IC<sub>50</sub> values of 7.74â€‰Â±â€‰2.50 for KE-37 and of 16.21â€‰Â±â€‰2.33 for K-562 when compared with the standard drug cisplatin<a href="#CIT0060"><sup>60</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 37.</span></a></div>   <p>Ru(III) containing methylbenzothiazole derivative <b>60</b>.</p>   </div> <p>Yurttas etÂ al. obtained benzothiazole derivatives by acetylation of substituted benzothiazole with chloroacetyl chloride that was further treated in series of reactions to obtain specific derivatives which were tested for their anticancer activities against lung carcinoma (A549) cell line. Derivatives <b>61</b> and derivative <b>62</b> (<a href="#F0038">Figure 38</a>) exhibited good anticancer activities against A549 with IC<sub>50</sub> values of 10.67â€‰Â±â€‰2.02 Âµg/mL and 9.0â€‰Â±â€‰1.0 Âµg/mL respectively as compared to the reference compound cisplatin<a href="#CIT0061"><sup>61</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 38.</span></a></div>   <p>Benzimidazole based acetamide methoxybenzothiazole derivative <b>61</b> and acetamide ethoxybenzothiazole derivative <b>62</b>.</p>   </div> <p>Oanh etÂ al. reported the synthesis of hydroxamic acids containing benzothiazole by the reaction of 2-aminobenzothiazole with adipic acid to produce esters that were converted into the desired BTA hydroxamates, and tested for their anticancer activities against five different cell lines such MCF-7, AsPC-1, SW620, PC3 and NCI-H460. Among the synthesised derivatives, hydroxamic acids <b>63</b> and <b>64</b> (<a href="#F0039">Figure 39</a>) exhibited good anticancer activities, with the average IC<sub>50</sub> value of 0.81â€‰Âµg/mL and 1.28â€‰Âµg/mL respectively<a href="#CIT0062"><sup>62</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 39.</span></a></div>   <p>Hydroxamic acid containing methyl/methoxy benzothiazole scaffolds <b>63</b> and <b>64</b>.</p>   </div> <p>Rodrigues etÂ al. synthesised carbohydrazide containing BTA derivatives and studied their antitumor activities against human prostate cancer cell lines. <i>N</i>â€²-formyl-2â€"(5-nitrothiophen-2-yl)benzothiazole-6-carbohydrazide <b>65</b> (<a href="#F0040">Figure 40</a>) exhibited potent anticancer activity against PC-3 and LNCaP having IC<sub>50</sub> values 19.9â€‰Â±â€‰1.17 and 11.2â€‰Â±â€‰0.79â€‰Âµg/m respectively<a href="#CIT0063"><sup>63</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 40.</span></a></div>   <p>Derivative <b>65â€"67</b> discussed in the article.</p>   </div> <p>Rao etÂ al. reportyed DNA-intercalating naphthalimide-benzothiazole derivatives and evaluated their cytotoxicities against three different cancer cell lines such as HT29, A549 and MCF-7. Among all tested derivatives, the naphthalimide derivative <b>66</b> (<a href="#F0040">Figure 40</a>) possessed good antitumor activity against HT-29, A549 and MCF-7 cell lines having IC<sub>50</sub> values of 3.72â€‰Â±â€‰0.3â€‰ÂµM, 4.074â€‰Â±â€‰0.3â€‰ÂµM and 07.91â€‰Â±â€‰0.4â€‰ÂµM respectively. The naphthalimide <b>67</b> (<a href="#F0040">Figure 40</a>) showed antitumor activity with IC<sub>50</sub> values of 03.47â€‰Â±â€‰0.2â€‰ÂµM for HT-29, 03.89â€‰Â±â€‰0.3â€‰ÂµM for A549 and 05.08â€‰Â±â€‰0.3â€‰ÂµM for MCF-7 cell lines<a href="#CIT0064"><sup>64</sup></a>.</p> <p>Rao etÂ al. reported the synthesis of 2-arylaminobenzothiazole-arylpropeonones and studied their cytotoxic activities against different human cancer cell lines. Among all synthesised derivatives, substituted phenylamino based methoxybenzothiazole <b>68</b> (<a href="#F0041">Figure 41</a>) and substituted phenylamino based methoxy methylbenzothiazole <b>69</b> (<a href="#F0041">Figure 41</a>) showed potent cytotoxic activity against HeLa cell lines possessing IC<sub>50</sub> values of 0.5â€‰Â±â€‰0.02 and 0.6â€‰Â±â€‰0.29â€‰ÂµM<a href="#CIT0065"><sup>65</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 41.</span></a></div>   <p>Substituted phenylamino based methoxy benzothiazoles <b>68</b> and <b>69</b>.</p>   </div> <p>Osmaniye etÂ al. synthesised benzothiazole-thiazolidine derivatives and studied their anticancer activities against C6 and healthy NIH3T3 cell lines. Among the synthesised derivatives, substituted phenylthizolidene based benzothiazole <b>70</b> and substituted nitrophenylthizolidene benzothiazole <b>71</b> (<a href="#F0042">Figure 42</a>) exhibited some cytotoxic activities against C6 cell line showing IC<sub>50</sub> value 0.03â€‰mM. The SAR studies showed that the presence of a phenyl group on the thiazolidine part of the structure increased the selectivity while substitution with an electron withdrawing or donating groups decreased the selectivity<a href="#CIT0066"><sup>66</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 42.</span></a></div>   <p>Substituted phenylthizolidene based benzothiazole derivative <b>70</b> and <b>71</b>.</p>   </div> <div class="benzothiazolederivativeswithcarbonicanhydraseinhibitoryandantitumoraction" title="sec"> <div class="title" tagx="title" title="title">
Benzothiazole derivatives with carbonic anhydrase inhibitory and antitumor action</div> <p>Carbonic anhydrases (CAs, EC 4.2.1.1) are zinc enzymes which catalyse the reversible interconversion between CO<sub>2</sub> and bicarbonate<a href="#CIT0067"><sup>67â€"71</sup></a>. CO<sub>2</sub> is efficiently hydrated through a zinc hydroxide intermediate from the enzyme active site with generation of the weak base bicarbonate and the strong acid H<sup>+</sup>. As a consequence, CAs are involved in pH regulation, electrolyte secretion and metabolism, in normal and tumour tissues<a href="#CIT0070"><sup>70â€"72</sup></a>. Fifteen Î±-CA isoforms are present in humans, with at least two of tyhem overexporessed in hypoxic tumours (CA IX and XII)<a href="#CIT0067"><sup>67</sup></a><sup>,</sup><a href="#CIT0071"><sup>71</sup></a><sup>,</sup><a href="#CIT0072"><sup>72</sup></a>, as a consequence of the hypoxia inducible factor (HIF-1Î±) transcription factor cascade activation<a href="#CIT0067"><sup>67</sup></a><sup>,</sup><a href="#CIT0070"><sup>70</sup></a>. CAs are efficiently inhibited by a range of compounds, such as the sulphonamides and their isosteres<a href="#CIT0073"><sup>73â€"76</sup></a>, and inorganic anions<a href="#CIT0077"><sup>77</sup></a>, which constitute the main zinc-binding CA inhibitor (CAI) classes<a href="#CIT0067"><sup>67</sup></a><sup>,</sup><a href="#CIT0076"><sup>76</sup></a><sup>,</sup><a href="#CIT0077"><sup>77</sup></a>. Some of the CAIs belonging to the sulphonamide<a href="#CIT0078"><sup>78</sup></a>, sulfocoumarin<a href="#CIT0079"><sup>79</sup></a>, saccharin<a href="#CIT0080"><sup>80</sup></a> or other structurally related chemotypes<a href="#CIT0081"><sup>81</sup></a><sup>,</sup><a href="#CIT0082"><sup>82</sup></a>, were shown to possess significant antitumor effects, with one such derivative (<b>SLC-0111</b>) in Phase I/IIb clinical trials for the management of hypoxic metastatic tumours<a href="#CIT0078"><sup>78</sup></a><sup>,</sup><a href="#CIT0083"><sup>83</sup></a>. Indeed, by inhibiting the tumour-associated isoforms CA IX and XII, such CAIs interfere with the pH regulation and metabolism of tumours, leading to the inhibition of growth of the primary tumour, metastases and reducing the population of cancer stem cells<a href="#CIT0078"><sup>78</sup></a>. As a consequence, many CAIs belonging to various classes are nowadays investigated for their antitumor/antimetastatic effects, including many BTA derivatives (<a href="#F0043">Figure 43</a>)<a href="#CIT0084"><sup>84â€"91</sup></a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 43.</span></a></div>   <p>Benzothiazoles with potent CA IX inhibitory action<a href="#CIT0084"><sup>84â€"91</sup></a>.</p>   </div> <p>.Indeed, using the ethoxzolamide <b>72</b>, a CAI in clinical use for decades as lead molecule, a multitude of primary sulphonamides (e.g. compounds <b>73â€"75</b>) as well as the secondary siulfonamide 76 were reported to act as highly efficient, frequently low nanomolar inhibitors against the tumour-associated isoforms CA IX and XII<a href="#CIT0084"><sup>84â€"91</sup></a>. No <i>ex vivo</i> or <i>inÂ vivo</i> studies are available so far with these potent CA IX/XII inhibitors, but compounds belonging to other classes of sulphonamides were proved to possess significant antitumor effects inÂ vivo when they act as potent inhibitors of these two CA isoforms<a href="#CIT0078"><sup>78</sup></a><sup>,</sup><a href="#CIT0092"><sup>92â€"98</sup></a>. Thus future studes may address this issue, considering the fact that the BTA scaffold present in these compounds may induce interesting phisico-chemical and pharmacologic properties to the CA IX/XII inhibitors, of which many chemical families are alredy reported<a href="#CIT0099"><sup>99â€"103</sup></a>.</p> </div> </div> </div> <div class="conclusions" title="sec"><span class="label" tagx="label" title="label">4.</span><div class="title" tagx="title" title="title">
Conclusions</div> <p>Benzothiazole is a pharmacophore widely used in medicinal chemistry. This review points out to a growing interest in the development of lead or hybrid structures bearing the BTA moiety as antiproliferative and anticancer agents. The present work describes the potential of BTA scaffolds in the management of various types of cancers such as ovarian, prostate, central nervous system, renal, gastric, pancreatic, liver, breast and colon cancers. SAR studies reaveled that the anticancer activity of BTA scaffolds depends upon the nature of substituents present in these molecules, being multifactorial and not always easy to rationalise. The plethora of research on the anticancer profile of BTA derivatives mentioned in this review and their rationalisation based on the drug targets of these derivatives, when this was possible, may be useful for the development of novel such agents.</p> </div> </div> <div class="back" title="back"> <div class="COI-statement" title="COI-statement"> <div class="title" tagx="title" title="title">
Disclosure statement</div> <p>No potential conflict of interest was reported by the authors.</p> </div> <div class="references">
References</div> <div tag="ref-list"> <ul> <div class="title" tagx="title" title="title">
References</div> <li tag="ref"><a name="CIT0001" /><span class="label" tagx="label" title="label">1</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Akhtar</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Khan</span><span class="given-names" tagx="given-names" title="given-names">AA</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ali</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Structure-activity relationship (SAR) study and design strategies of nitrogen-containing heterocyclic moieties for their anticancer activities</span>. <span class="source" tagx="source" title="source">Eur J Med Chem</span><span class="year" tagx="year" title="year">2017</span>;<span class="volume" tagx="volume" title="volume">5</span>:<span class="fpage" tagx="fpage" title="fpage">143</span>â€"<span class="lpage" tagx="lpage" title="lpage">89</span>.</span></li> <li tag="ref"><a name="CIT0002" /><span class="label" tagx="label" title="label">2</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Keri</span><span class="given-names" tagx="given-names" title="given-names">SR</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Patil</span><span class="given-names" tagx="given-names" title="given-names">RM</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Patil</span><span class="given-names" tagx="given-names" title="given-names">AS</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Budagumpi</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">A comprehensive review in current developments of benzothiazole-based molecules in medicinal chemistry</span>. <span class="source" tagx="source" title="source">Eur J Med Chem</span><span class="year" tagx="year" title="year">2015</span>;<span class="volume" tagx="volume" title="volume">89</span>:<span class="fpage" tagx="fpage" title="fpage">207</span>â€"<span class="lpage" tagx="lpage" title="lpage">51</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25462241">25462241</a></span></span></li> <li tag="ref"><a name="CIT0003" /><span class="label" tagx="label" title="label">3</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gunawardana</span><span class="given-names" tagx="given-names" title="given-names">GP</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Koehn</span><span class="given-names" tagx="given-names" title="given-names">FE</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">AY</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Pyridoacridine alkaloids from deep water marine sponges of the family Pachastrellidae: structure revision of dercitin and related compounds and correlation with the Kuanoniamines</span>. <span class="source" tagx="source" title="source">J Org Chem</span><span class="year" tagx="year" title="year">1992</span>;<span class="volume" tagx="volume" title="volume">57</span>:<span class="fpage" tagx="fpage" title="fpage">1523</span>â€"<span class="lpage" tagx="lpage" title="lpage">6</span>.</span></li> <li tag="ref"><a name="CIT0004" /><span class="label" tagx="label" title="label">4</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jaiswal</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mishra</span><span class="given-names" tagx="given-names" title="given-names">PA</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Srivastava</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">The different kinds of reaction involved in synthesis of 2-substituted 2enzothiazole and its derivatives: a review</span>. <span class="source" tagx="source" title="source">Res J Pharm Biol Chem Sci</span><span class="year" tagx="year" title="year">2012</span>;<span class="volume" tagx="volume" title="volume">3</span>:<span class="fpage" tagx="fpage" title="fpage">631</span>â€"<span class="lpage" tagx="lpage" title="lpage">41</span>.</span></li> <li tag="ref"><a name="CIT0005" /><span class="label" tagx="label" title="label">5</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bryson</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fulton</span><span class="given-names" tagx="given-names" title="given-names">B</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Benfield</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Riluzole a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis</span>. <span class="source" tagx="source" title="source">Drugs</span><span class="year" tagx="year" title="year">1996</span>;<span class="volume" tagx="volume" title="volume">52</span>:<span class="fpage" tagx="fpage" title="fpage">549</span>â€"<span class="lpage" tagx="lpage" title="lpage">63</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8891467">8891467</a></span></span></li> <li tag="ref"><a name="CIT0006" /><span class="label" tagx="label" title="label">6</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Venkatesh</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pandeya</span><span class="given-names" tagx="given-names" title="given-names">NS.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis, characterisation and anti-inflammatory activity of some 2-amino benzothiazole derivatives</span>. <span class="source" tagx="source" title="source">Int J ChemTech Res</span><span class="year" tagx="year" title="year">2009</span>;<span class="volume" tagx="volume" title="volume">1</span>:<span class="fpage" tagx="fpage" title="fpage">1354</span>â€"<span class="lpage" tagx="lpage" title="lpage">8</span>.</span></li> <li tag="ref"><a name="CIT0007" /><span class="label" tagx="label" title="label">7</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dong</span><span class="given-names" tagx="given-names" title="given-names">G</span></span></span>, et.al. <span class="mixed-article-title" title="mixed-article-title">Novel benzothiazole derivatives with a broad antifungal spectrum: design, synthesis and structureâ€"activity relationships</span>. <span class="source" tagx="source" title="source">Med Chem Commun</span><span class="year" tagx="year" title="year">2013</span>;<span class="volume" tagx="volume" title="volume">4</span>:<span class="fpage" tagx="fpage" title="fpage">1551</span>â€"<span class="lpage" tagx="lpage" title="lpage">61</span>.</span></li> <li tag="ref"><a name="CIT0008" /><span class="label" tagx="label" title="label">8</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mats</span><span class="given-names" tagx="given-names" title="given-names">ME</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shani</span><span class="given-names" tagx="given-names" title="given-names">BG</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pasternak</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis and mechanism of hypoglycemic activity of benzothiazole derivatives</span>. <span class="source" tagx="source" title="source">J Med Chem</span><span class="year" tagx="year" title="year">2013</span>;<span class="volume" tagx="volume" title="volume">56</span>:<span class="fpage" tagx="fpage" title="fpage">5335</span>â€"<span class="lpage" tagx="lpage" title="lpage">50</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23750537">23750537</a></span></span></li> <li tag="ref"><a name="CIT0009" /><span class="label" tagx="label" title="label">9</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bele</span><span class="given-names" tagx="given-names" title="given-names">DS</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Singhvi</span><span class="given-names" tagx="given-names" title="given-names">I.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis and analgesic activity of some Mannich bases of 6-substituted-2-aminobenzothiazole</span>. <span class="source" tagx="source" title="source">Res J Pharm and Tech</span><span class="year" tagx="year" title="year">2008</span>;<span class="volume" tagx="volume" title="volume">1</span>:<span class="fpage" tagx="fpage" title="fpage">22</span>â€"<span class="lpage" tagx="lpage" title="lpage">4</span>.</span></li> <li tag="ref"><a name="CIT0010" /><span class="label" tagx="label" title="label">10</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Padalkar</span><span class="given-names" tagx="given-names" title="given-names">SV</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gupta</span><span class="given-names" tagx="given-names" title="given-names">DV</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Phatangare</span><span class="given-names" tagx="given-names" title="given-names">RK</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis of novel dipodal-benzimidazole, benzoxazole and benzothiazole from cyanuric chloride: structural, photophysical and antimicrobial studies</span>. <span class="source" tagx="source" title="source">J Saudi Chem Soc</span><span class="year" tagx="year" title="year">2014</span>;<span class="volume" tagx="volume" title="volume">18</span>:<span class="fpage" tagx="fpage" title="fpage">262</span>â€"<span class="lpage" tagx="lpage" title="lpage">8</span>.</span></li> <li tag="ref"><a name="CIT0011" /><span class="label" tagx="label" title="label">11</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cai</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sun</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Design and synthesis of novel 4-benzothiazole amino quinazolines Dasatinib derivatives as potential anti-tumor agents</span>. <span class="source" tagx="source" title="source">Eur J Med Chem</span><span class="year" tagx="year" title="year">2013</span>;<span class="volume" tagx="volume" title="volume">63</span>:<span class="fpage" tagx="fpage" title="fpage">702</span>â€"<span class="lpage" tagx="lpage" title="lpage">12</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23567960">23567960</a></span></span></li> <li tag="ref"><a name="CIT0012" /><span class="label" tagx="label" title="label">12</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Delmas</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Avellaneda</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Giorgio</span><span class="given-names" tagx="given-names" title="given-names">DC</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis and antileishmanial activity of (1,3-benzothiazol-2-yl) amino-9-(10H)-acridinone derivatives</span>. <span class="source" tagx="source" title="source">Eur J Med Chem</span><span class="year" tagx="year" title="year">2004</span>;<span class="volume" tagx="volume" title="volume">39</span>:<span class="fpage" tagx="fpage" title="fpage">685</span>â€"<span class="lpage" tagx="lpage" title="lpage">90</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15276301">15276301</a></span></span></li> <li tag="ref"><a name="CIT0013" /><span class="label" tagx="label" title="label">13</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Munirajasekhar</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Himaja</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sunil</span><span class="given-names" tagx="given-names" title="given-names">VM.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis and anthelmintic activity of 2-amino-6- substituted benzothiazoles</span>. <span class="source" tagx="source" title="source">Int Res J Pharm</span><span class="year" tagx="year" title="year">2011</span>;<span class="volume" tagx="volume" title="volume">2</span>:<span class="fpage" tagx="fpage" title="fpage">114</span>â€"<span class="lpage" tagx="lpage" title="lpage">7</span>.</span></li> <li tag="ref"><a name="CIT0014" /><span class="label" tagx="label" title="label">14</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yadav</span><span class="given-names" tagx="given-names" title="given-names">SP</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Devprakash</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Senthilkumar</span><span class="given-names" tagx="given-names" title="given-names">GP.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Benzothiazole: different methods of synthesis and diverse biological activities</span>. <span class="source" tagx="source" title="source">Int J Pharm Sci Drug Res</span><span class="year" tagx="year" title="year">2011</span>;<span class="volume" tagx="volume" title="volume">3</span>:<span class="fpage" tagx="fpage" title="fpage">01</span>â€"<span class="lpage" tagx="lpage" title="lpage">7</span>.</span></li> <li tag="ref"><a name="CIT0015" /><span class="label" tagx="label" title="label">15</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Siddiqui</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rana</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Khan</span><span class="given-names" tagx="given-names" title="given-names">AS</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis of benzothiazole semicarbazones as novel anticonvulsantsâ€"the role of hydrophobic domain</span>. <span class="source" tagx="source" title="source">Bioorg Med Chem Lett</span><span class="year" tagx="year" title="year">2007</span>;<span class="volume" tagx="volume" title="volume">17</span>:<span class="fpage" tagx="fpage" title="fpage">4178</span>â€"<span class="lpage" tagx="lpage" title="lpage">82</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17572089">17572089</a></span></span></li> <li tag="ref"><a name="CIT0016" /><span class="label" tagx="label" title="label">16</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shi</span><span class="given-names" tagx="given-names" title="given-names">HX</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xia</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis and biological evaluation of novel benzothiazole-2-thiol derivatives as potential anticancer agents</span>. <span class="source" tagx="source" title="source">Molecules</span><span class="year" tagx="year" title="year">2012</span>;<span class="volume" tagx="volume" title="volume">17</span>:<span class="fpage" tagx="fpage" title="fpage">3933</span>â€"<span class="lpage" tagx="lpage" title="lpage">44</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22466853">22466853</a></span></span></li> <li tag="ref"><a name="CIT0017" /><span class="label" tagx="label" title="label">17</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Leong</span><span class="given-names" tagx="given-names" title="given-names">CO</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Suggitt</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Swaine</span><span class="given-names" tagx="given-names" title="given-names">DJ</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">In vitro, inÂ vivo, and in silico analyses of the antitumor activity of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazoles</span>. <span class="source" tagx="source" title="source">Mol Cancer Ther</span><span class="year" tagx="year" title="year">2004</span>;<span class="volume" tagx="volume" title="volume">3</span>:<span class="fpage" tagx="fpage" title="fpage">1565</span>â€"<span class="lpage" tagx="lpage" title="lpage">75</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15634650">15634650</a></span></span></li> <li tag="ref"><a name="CIT0018" /><span class="label" tagx="label" title="label">18</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mortimer</span><span class="given-names" tagx="given-names" title="given-names">CG</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wells</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Crochard</span><span class="given-names" tagx="given-names" title="given-names">JP</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Antitumor benzothiazoles. 26.1 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective Inhibitory activity against lung, colon, and breast cancer cell lines</span>. <span class="source" tagx="source" title="source">J Med Chem</span><span class="year" tagx="year" title="year">2006</span>;<span class="volume" tagx="volume" title="volume">49</span>:<span class="fpage" tagx="fpage" title="fpage">179</span>â€"<span class="lpage" tagx="lpage" title="lpage">85</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16392802">16392802</a></span></span></li> <li tag="ref"><a name="CIT0019" /><span class="label" tagx="label" title="label">19</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Baffy</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Hepatocellular carcinoma in type 2 diabetes: more than meets the eye</span>. <span class="source" tagx="source" title="source">Am J Gastroenterol</span><span class="year" tagx="year" title="year">2012</span>;<span class="volume" tagx="volume" title="volume">107</span>:<span class="fpage" tagx="fpage" title="fpage">53</span>â€"<span class="lpage" tagx="lpage" title="lpage">5</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22218030">22218030</a></span></span></li> <li tag="ref"><a name="CIT0020" /><span class="label" tagx="label" title="label">20</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">McCutcheon</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span> Where have my eyebrows gone? Cengage learning. 2019. ISBN 07668393462001;5.</span></li> <li tag="ref"><a name="CIT0021" /><span class="label" tagx="label" title="label">21</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Anand</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kunnumakara</span><span class="given-names" tagx="given-names" title="given-names">AB</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sundaram</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Cancer is a preventable disease that requires major lifestyle changes</span>. <span class="source" tagx="source" title="source">Pharm Res</span><span class="year" tagx="year" title="year">2008</span>;<span class="volume" tagx="volume" title="volume">25</span>:<span class="fpage" tagx="fpage" title="fpage">2097</span>â€"<span class="lpage" tagx="lpage" title="lpage">116</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18626751">18626751</a></span></span></li> <li tag="ref"><a name="CIT0022" /><span class="label" tagx="label" title="label">22</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kumbhare</span><span class="given-names" tagx="given-names" title="given-names">MR</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dadmal</span><span class="given-names" tagx="given-names" title="given-names">T</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kosurkar</span><span class="given-names" tagx="given-names" title="given-names">U</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis and cytotoxic evaluation of thiourea and N-bis-benzothiazolederivatives: a novel class of cytotoxic agents</span>. <span class="source" tagx="source" title="source">Bioorg Med Chem Lett</span><span class="year" tagx="year" title="year">2012</span>; <span class="volume" tagx="volume" title="volume">22</span>:<span class="fpage" tagx="fpage" title="fpage">453</span>â€"<span class="lpage" tagx="lpage" title="lpage">5</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22115593">22115593</a></span></span></li> <li tag="ref"><a name="CIT0023" /><span class="label" tagx="label" title="label">23</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kumbhare</span><span class="given-names" tagx="given-names" title="given-names">MR</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kumar</span><span class="given-names" tagx="given-names" title="given-names">VK</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ramaiah</span><span class="given-names" tagx="given-names" title="given-names">JM</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis and biological evaluation of novel Mannich bases of 2-arylimidazo[2,1- b]benzothi azoles as potential anti-cancer agents</span>. <span class="source" tagx="source" title="source">Eur J Med Chem</span><span class="year" tagx="year" title="year">2011</span>;<span class="volume" tagx="volume" title="volume">46</span>:<span class="fpage" tagx="fpage" title="fpage">4258</span>â€"<span class="lpage" tagx="lpage" title="lpage">66</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21775028">21775028</a></span></span></li> <li tag="ref"><a name="CIT0024" /><span class="label" tagx="label" title="label">24</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">El-Damasy</span><span class="given-names" tagx="given-names" title="given-names">KA</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">HJ</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Seo</span><span class="given-names" tagx="given-names" title="given-names">HS</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Design and synthesis of new potent anticancer benzothiazole amides and ureas featuring pyridylamide moiety and possessing dual B-Raf<sup>V600E</sup> and C-Raf kinase inhibitory activities</span>. <span class="source" tagx="source" title="source">Eur J Med Chem</span><span class="year" tagx="year" title="year">2016</span>;<span class="volume" tagx="volume" title="volume">115</span>:<span class="fpage" tagx="fpage" title="fpage">201</span>â€"<span class="lpage" tagx="lpage" title="lpage">16</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27017549">27017549</a></span></span></li> <li tag="ref"><a name="CIT0025" /><span class="label" tagx="label" title="label">25</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ma</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Han</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis and biological evaluation of benzothiazole derivatives bearing theortho hydroxy- N â€"acylhydrazone moiety as potent antitumor agents</span>. <span class="source" tagx="source" title="source">Arch Pharm Chem Life Sci</span><span class="year" tagx="year" title="year">2014</span>;<span class="volume" tagx="volume" title="volume">347</span>:<span class="fpage" tagx="fpage" title="fpage">1</span>â€"<span class="lpage" tagx="lpage" title="lpage">14</span>.</span></li> <li tag="ref"><a name="CIT0026" /><span class="label" tagx="label" title="label">26</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gabr</span><span class="given-names" tagx="given-names" title="given-names">TM</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">El-Gohary</span><span class="given-names" tagx="given-names" title="given-names">SN</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">El-Bendary</span><span class="given-names" tagx="given-names" title="given-names">RE</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis, inÂ vitro antitumor activity and molecular modeling studies 4 of a new series of benzothiazole Schiff bases</span>. <span class="source" tagx="source" title="source">Chin Chem Lett</span><span class="year" tagx="year" title="year">2016</span>;<span class="volume" tagx="volume" title="volume">27</span>:<span class="fpage" tagx="fpage" title="fpage">380</span>â€"<span class="lpage" tagx="lpage" title="lpage">6</span>.</span></li> <li tag="ref"><a name="CIT0027" /><span class="label" tagx="label" title="label">27</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Junjie</span><span class="given-names" tagx="given-names" title="given-names">AM</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gang</span><span class="given-names" tagx="given-names" title="given-names">UH</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lijun</span><span class="given-names" tagx="given-names" title="given-names">EIX</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Design, synthesis and biological evaluation of novel benzothiazole derivatives bearing semicarbazone moiety as antitumor agents</span>. <span class="source" tagx="source" title="source">Chem Res Chin Univ</span><span class="year" tagx="year" title="year">2015</span>;<span class="volume" tagx="volume" title="volume">31</span>:<span class="fpage" tagx="fpage" title="fpage">958</span>â€"<span class="lpage" tagx="lpage" title="lpage">63</span>.</span></li> <li tag="ref"><a name="CIT0028" /><span class="label" tagx="label" title="label">28</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yurttas</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tay</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Demirayak</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis and antitumor activity evaluation of new 2-(4-aminophenyl)benzothiazole derivatives bearing different heterocyclic rings</span>. <span class="source" tagx="source" title="source">J Enzyme Inhib Med Chem</span><span class="year" tagx="year" title="year">2014</span>;<span class="volume" tagx="volume" title="volume">30</span>:<span class="fpage" tagx="fpage" title="fpage">458</span>â€"<span class="lpage" tagx="lpage" title="lpage">65</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25198890">25198890</a></span></span></li> <li tag="ref"><a name="CIT0029" /><span class="label" tagx="label" title="label">29</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Singh</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kaur</span><span class="given-names" tagx="given-names" title="given-names">B</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kaur</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">spectral studies and biological activity of 2, 3-disubstituted imidazo [2, 1-b] benzothiazole derivatives</span>. <span class="source" tagx="source" title="source">Indian J Pharmaceut Biol Res</span><span class="year" tagx="year" title="year">2018</span>;<span class="volume" tagx="volume" title="volume">6</span>:<span class="fpage" tagx="fpage" title="fpage">1</span>â€"<span class="lpage" tagx="lpage" title="lpage">8</span>.</span></li> <li tag="ref"><a name="CIT0030" /><span class="label" tagx="label" title="label">30</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Al-Soud</span><span class="given-names" tagx="given-names" title="given-names">AY</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Al-Saâ€™doni</span><span class="given-names" tagx="given-names" title="given-names">HH</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Saeed</span><span class="given-names" tagx="given-names" title="given-names">B</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis and inÂ vitro anti-proliferative activity of new benzothiazole derivatives</span>. <span class="source" tagx="source" title="source">ARKIVOC</span><span class="year" tagx="year" title="year">2008</span>;<span class="volume" tagx="volume" title="volume">2008</span>:<span class="fpage" tagx="fpage" title="fpage">225</span>â€"<span class="lpage" tagx="lpage" title="lpage">238</span>.</span></li> <li tag="ref"><a name="CIT0031" /><span class="label" tagx="label" title="label">31</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gurdal</span><span class="given-names" tagx="given-names" title="given-names">EE</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Durmaz</span><span class="given-names" tagx="given-names" title="given-names">I</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Atalay</span><span class="given-names" tagx="given-names" title="given-names">CR</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yarim</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Cytotoxic activities of some benzothiazole-piperazine derivatives</span>. <span class="source" tagx="source" title="source">J Enzyme Inhib Med Chem</span><span class="year" tagx="year" title="year">2015</span>;<span class="volume" tagx="volume" title="volume">30</span>:<span class="fpage" tagx="fpage" title="fpage">649</span>â€"<span class="lpage" tagx="lpage" title="lpage">54</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25333766">25333766</a></span></span></li> <li tag="ref"><a name="CIT0032" /><span class="label" tagx="label" title="label">32</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Akhtar</span><span class="given-names" tagx="given-names" title="given-names">T</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hameed</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Al-Masoudi</span><span class="given-names" tagx="given-names" title="given-names">AN</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">In vitro antitumor and antiviral activities of new benzothiazole and 1,3,4-oxadiazole-2-thione derivatives</span>. <span class="source" tagx="source" title="source">Acta Pharm</span><span class="year" tagx="year" title="year">2008</span>;<span class="volume" tagx="volume" title="volume">58</span>:<span class="fpage" tagx="fpage" title="fpage">135</span>â€"<span class="lpage" tagx="lpage" title="lpage">49</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18515224">18515224</a></span></span></li> <li tag="ref"><a name="CIT0033" /><span class="label" tagx="label" title="label">33</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Saeed</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rashid</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jones</span><span class="given-names" tagx="given-names" title="given-names">GP</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis, characterization and biological evaluation of some thiourea derivatives bearing benzothiazole moiety as potential antimicrobial and anticancer agents</span>. <span class="source" tagx="source" title="source">Eur J Med Chem</span><span class="year" tagx="year" title="year">2010</span>;<span class="volume" tagx="volume" title="volume">45</span>:<span class="fpage" tagx="fpage" title="fpage">1323</span>â€"<span class="lpage" tagx="lpage" title="lpage">31</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20056520">20056520</a></span></span></li> <li tag="ref"><a name="CIT0034" /><span class="label" tagx="label" title="label">34</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lei</span><span class="given-names" tagx="given-names" title="given-names">Q</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xia</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">A novel benzothiazole derivative SKLB826 inhibits human hepatocellular carcinoma growth via inducing G2/M phase arrest and apoptosis</span>. <span class="source" tagx="source" title="source">RSC Adv</span><span class="year" tagx="year" title="year">2015</span>;<span class="volume" tagx="volume" title="volume">5</span>:<span class="fpage" tagx="fpage" title="fpage">41341</span>.</span></li> <li tag="ref"><a name="CIT0035" /><span class="label" tagx="label" title="label">35</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Racane</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kulenovic</span><span class="given-names" tagx="given-names" title="given-names">TV</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pavelic</span><span class="given-names" tagx="given-names" title="given-names">KS</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Novel diamidino-substituted derivatives of phenyl benzothiazolyl and dibenzothia zolyl furans and thiophenes: synthesis, anti-proliferative and DNA binding properties</span>. <span class="source" tagx="source" title="source">J Med Chem</span><span class="year" tagx="year" title="year">2010</span>;<span class="volume" tagx="volume" title="volume">53</span>:<span class="fpage" tagx="fpage" title="fpage">2418</span>â€"<span class="lpage" tagx="lpage" title="lpage">32</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20170096">20170096</a></span></span></li> <li tag="ref"><a name="CIT0036" /><span class="label" tagx="label" title="label">36</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sekar</span><span class="given-names" tagx="given-names" title="given-names">V</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Perumal</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Arunachalam</span><span class="given-names" tagx="given-names" title="given-names">Â </span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gandhimathi</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Screening of anticancer activity in newly synthesized benzothiazole derivatives</span>. <span class="source" tagx="source" title="source">J Pharm Sci Res</span><span class="year" tagx="year" title="year">2011</span>;<span class="volume" tagx="volume" title="volume">3</span>:<span class="fpage" tagx="fpage" title="fpage">1520</span>â€"<span class="lpage" tagx="lpage" title="lpage">4</span>.</span></li> <li tag="ref"><a name="CIT0037" /><span class="label" tagx="label" title="label">37</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xuejiao</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yong</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ningyu</span><span class="given-names" tagx="given-names" title="given-names">W</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">A novel benzothiazole derivative YLT322 induces apoptosis via the mitochondrial apoptosis pathway inÂ vitro with anti-tumor activity in solid malignancies</span>. <span class="source" tagx="source" title="source">PLoS One</span><span class="year" tagx="year" title="year">2013</span>;<span class="volume" tagx="volume" title="volume">8</span>:<span class="fpage" tagx="fpage" title="fpage">e63900</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23737957">23737957</a></span></span></li> <li tag="ref"><a name="CIT0038" /><span class="label" tagx="label" title="label">38</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kamal</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ashraf</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Vardhan</span><span class="given-names" tagx="given-names" title="given-names">VSP</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis and anticancer potential of benzothiazole linked phenylpyridopyrimidinones and their diones as mitochondrial apoptotic inducers</span>. <span class="source" tagx="source" title="source">Bioorg Med Chem Lett</span><span class="year" tagx="year" title="year">2014</span>;<span class="volume" tagx="volume" title="volume">24</span>:<span class="fpage" tagx="fpage" title="fpage">147</span>â€"<span class="lpage" tagx="lpage" title="lpage">51</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/24332497">24332497</a></span></span></li> <li tag="ref"><a name="CIT0039" /><span class="label" tagx="label" title="label">39</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gabr</span><span class="given-names" tagx="given-names" title="given-names">TM</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">El-Gohary</span><span class="given-names" tagx="given-names" title="given-names">SN</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">El-Bendary</span><span class="given-names" tagx="given-names" title="given-names">RE</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">El-Kerdawy</span><span class="given-names" tagx="given-names" title="given-names">MM.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis and inÂ vitro antitumor activity of new series ofbenzothiazole and pyrimido[2,1-b]benzothiazole derivatives</span>. <span class="source" tagx="source" title="source">Euro J Med Chem</span><span class="year" tagx="year" title="year">2014</span>;<span class="volume" tagx="volume" title="volume">85</span>:<span class="fpage" tagx="fpage" title="fpage">576</span>â€"<span class="lpage" tagx="lpage" title="lpage">92</span>.</span></li> <li tag="ref"><a name="CIT0040" /><span class="label" tagx="label" title="label">40</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kumbhare</span><span class="given-names" tagx="given-names" title="given-names">MR</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dadmal</span><span class="given-names" tagx="given-names" title="given-names">LT</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Devi</span><span class="given-names" tagx="given-names" title="given-names">AT</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Isoxazole derivatives of 6-fluoro-N-(6-methoxybenzo[d]thiazol-2-yl)benzo[d]thiazol-2-amine and N-(pyrimidin-2-yl)benzo[d]thiazol-2-amine: regulation of cell cycle and apoptosis by p53 activation via mitochondrial-dependent pathways</span>. <span class="source" tagx="source" title="source">Med Chem Commun</span><span class="year" tagx="year" title="year">2014</span>;<span class="volume" tagx="volume" title="volume">5</span>:<span class="fpage" tagx="fpage" title="fpage">1744</span>.</span></li> <li tag="ref"><a name="CIT0041" /><span class="label" tagx="label" title="label">41</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Waghmare</span><span class="given-names" tagx="given-names" title="given-names">SG</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chidrawar</span><span class="given-names" tagx="given-names" title="given-names">BA</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bhosale</span><span class="given-names" tagx="given-names" title="given-names">NV</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis and in-vitro anticancer activity of 3-cyano-6,9-dimethyl-4-imino 2-methylthio 4H-pyrimido [2,1-b] [1,3] benzothiazole and its 2-substituted derivative</span>. <span class="source" tagx="source" title="source">J Pharm Res</span><span class="year" tagx="year" title="year">2013</span>;<span class="volume" tagx="volume" title="volume">7</span>:<span class="fpage" tagx="fpage" title="fpage">823</span>â€"<span class="lpage" tagx="lpage" title="lpage">7</span>.</span></li> <li tag="ref"><a name="CIT0042" /><span class="label" tagx="label" title="label">42</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Caleta</span><span class="given-names" tagx="given-names" title="given-names">I</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kralj</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Marjanovic</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Novel cyano- and amidinobenzothiazole derivatives: synthesis, antitumor evaluation, and X-ray and quantitative structure-activity relationship (QSAR) analysis</span>. <span class="source" tagx="source" title="source">J Med Chem</span><span class="year" tagx="year" title="year">2009</span>;<span class="volume" tagx="volume" title="volume">52</span>:<span class="fpage" tagx="fpage" title="fpage">1744</span>â€"<span class="lpage" tagx="lpage" title="lpage">56</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19265399">19265399</a></span></span></li> <li tag="ref"><a name="CIT0043" /><span class="label" tagx="label" title="label">43</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Osmaniye</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Levent</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Karaduman</span><span class="given-names" tagx="given-names" title="given-names">BA</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis of new benzothiazole acylhydrazones as anticancer agents</span>. <span class="source" tagx="source" title="source">Molecules</span><span class="year" tagx="year" title="year">2018</span>;<span class="volume" tagx="volume" title="volume">23</span>:<span class="fpage" tagx="fpage" title="fpage">1054</span>.</span></li> <li tag="ref"><a name="CIT0044" /><span class="label" tagx="label" title="label">44</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lad</span><span class="given-names" tagx="given-names" title="given-names">NP</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Manohar</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mascarenhas</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Methylsulfonyl benzothiazoles (MSBT) derivatives: search for new potential antimicrobial and anticancer agents</span>. <span class="source" tagx="source" title="source">Bioorg Med Chem Lett</span><span class="year" tagx="year" title="year">2017</span>; <span class="volume" tagx="volume" title="volume">27</span>:<span class="fpage" tagx="fpage" title="fpage">1319</span>â€"<span class="lpage" tagx="lpage" title="lpage">24</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28188067">28188067</a></span></span></li> <li tag="ref"><a name="CIT0045" /><span class="label" tagx="label" title="label">45</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sadhasivam</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kulanthai</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Natarajan</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis and anti-cancer Studies of 2, 6-disubstituted benzothiazole derivatives</span>. <span class="source" tagx="source" title="source">Orient J Chem</span><span class="year" tagx="year" title="year">2015</span>;<span class="volume" tagx="volume" title="volume">31</span>:<span class="fpage" tagx="fpage" title="fpage">819</span>â€"<span class="lpage" tagx="lpage" title="lpage">26</span>.</span></li> <li tag="ref"><a name="CIT0046" /><span class="label" tagx="label" title="label">46</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shi</span><span class="given-names" tagx="given-names" title="given-names">HX</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis, structureâ€"activity relationships and preliminary antitumor evaluation of benzothiazole-2-thiol derivatives as novel apoptosis inducers</span>. <span class="source" tagx="source" title="source">Bioorg Med Chem Lett</span><span class="year" tagx="year" title="year">2011</span>;<span class="volume" tagx="volume" title="volume">21</span>:<span class="fpage" tagx="fpage" title="fpage">1097</span>â€"<span class="lpage" tagx="lpage" title="lpage">101</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21262571">21262571</a></span></span></li> <li tag="ref"><a name="CIT0047" /><span class="label" tagx="label" title="label">47</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bolelli</span><span class="given-names" tagx="given-names" title="given-names">k</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Musdal</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Aki-Yalcin</span><span class="given-names" tagx="given-names" title="given-names">E</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis and activity mechanism of some novel 2-substituted benzothiazoles as hGSTP1-1 enzyme inhibitors</span>. <span class="source" tagx="source" title="source">SAR QSAR Environ Res</span><span class="year" tagx="year" title="year">2017</span>;<span class="volume" tagx="volume" title="volume">28</span>:<span class="fpage" tagx="fpage" title="fpage">927</span>â€"<span class="lpage" tagx="lpage" title="lpage">40</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29206502">29206502</a></span></span></li> <li tag="ref"><a name="CIT0048" /><span class="label" tagx="label" title="label">48</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Corbo</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Carocci</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Armenise</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Antiproliferative activity evaluation of a series of N-1,3-benzothiazol-2-ylbenzamides as novel apoptosis inducers</span>. <span class="source" tagx="source" title="source">J Chem</span><span class="year" tagx="year" title="year">2016</span>;<span class="volume" tagx="volume" title="volume">5</span>:<span class="fpage" tagx="fpage" title="fpage">4267564</span>.</span></li> <li tag="ref"><a name="CIT0049" /><span class="label" tagx="label" title="label">49</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Abdelgawad</span><span class="given-names" tagx="given-names" title="given-names">AM</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lamie</span><span class="given-names" tagx="given-names" title="given-names">FP</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ahmed</span><span class="given-names" tagx="given-names" title="given-names">MO.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis of new quinolone derivatives linked to benzothiazole or benzoxazole moieties as anticancer and anti-oxidant agents</span>. <span class="source" tagx="source" title="source">Med Chem</span><span class="year" tagx="year" title="year">2016</span>;<span class="volume" tagx="volume" title="volume">6</span>: <span class="fpage" tagx="fpage" title="fpage">31</span>â€"9.</span></li> <li tag="ref"><a name="CIT0050" /><span class="label" tagx="label" title="label">50</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sarkar</span><span class="given-names" tagx="given-names" title="given-names">B</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Maiti</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jadhav</span><span class="given-names" tagx="given-names" title="given-names">RG</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Paira</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Benzothiazolylquinoline conjugates as novel human A3 receptor antagonists: biological evaluations and molecular docking studies</span>. <span class="source" tagx="source" title="source">R Soc Open Sci</span><span class="year" tagx="year" title="year">2018</span>;<span class="volume" tagx="volume" title="volume">5</span>:<span class="fpage" tagx="fpage" title="fpage">171622</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29515874">29515874</a></span></span></li> <li tag="ref"><a name="CIT0051" /><span class="label" tagx="label" title="label">51</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tay</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">YurttaÅŸ</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Demirayak</span><span class="given-names" tagx="given-names" title="given-names">Åž.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis of some N-[4-(benzothiazole-2yl) phenyl]-2-aryloxyacetamide derivatives and their anticancer activities</span>. <span class="source" tagx="source" title="source">J Enzyme Inhib Med Chem</span><span class="year" tagx="year" title="year">2012</span>;<span class="volume" tagx="volume" title="volume">27</span>:<span class="fpage" tagx="fpage" title="fpage">515</span>â€"<span class="lpage" tagx="lpage" title="lpage">20</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21823837">21823837</a></span></span></li> <li tag="ref"><a name="CIT0052" /><span class="label" tagx="label" title="label">52</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Noolvi</span><span class="given-names" tagx="given-names" title="given-names">NM</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Patel</span><span class="given-names" tagx="given-names" title="given-names">MH</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kaur</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Benzothiazoles: search for anticancer agents</span>. <span class="source" tagx="source" title="source">Eur J Med Chem</span><span class="year" tagx="year" title="year">2012</span>;<span class="volume" tagx="volume" title="volume">54</span>:<span class="fpage" tagx="fpage" title="fpage">447</span>â€"<span class="lpage" tagx="lpage" title="lpage">62</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22703845">22703845</a></span></span></li> <li tag="ref"><a name="CIT0053" /><span class="label" tagx="label" title="label">53</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Havrylyuk</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mosula</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zimenkovsky</span><span class="given-names" tagx="given-names" title="given-names">B</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis and anticancer activity evaluation of 4-thiazolidinones containing benzothiazole moiety</span>. <span class="source" tagx="source" title="source">Eur J Med Chem</span><span class="year" tagx="year" title="year">2010</span>;<span class="volume" tagx="volume" title="volume">45</span>:<span class="fpage" tagx="fpage" title="fpage">5012</span>â€"<span class="lpage" tagx="lpage" title="lpage">21</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20810193">20810193</a></span></span></li> <li tag="ref"><a name="CIT0054" /><span class="label" tagx="label" title="label">54</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Prabhu</span><span class="given-names" tagx="given-names" title="given-names">PP</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Panneerselvam</span><span class="given-names" tagx="given-names" title="given-names">T</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shastry</span><span class="given-names" tagx="given-names" title="given-names">SC</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis and anticancer evaluation of 2-phenyl thiaolidinone substituted 2-phenyl benzothiazole-6-carboxylic acid derivatives</span>. <span class="source" tagx="source" title="source">J Saudi Chem Soc</span><span class="year" tagx="year" title="year">2015</span>;<span class="volume" tagx="volume" title="volume">19</span>:<span class="fpage" tagx="fpage" title="fpage">181</span>â€"<span class="lpage" tagx="lpage" title="lpage">5</span>.</span></li> <li tag="ref"><a name="CIT0055" /><span class="label" tagx="label" title="label">55</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Abdelgawad</span><span class="given-names" tagx="given-names" title="given-names">AM</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Belal</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ahmed</span><span class="given-names" tagx="given-names" title="given-names">MO.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis, molecular docking studies and cytotoxic screening of certain novel thiazolidinone derivatives substituted with benzothiazole or benzoxazole</span>. <span class="source" tagx="source" title="source">J Chem. pharm Sci</span><span class="year" tagx="year" title="year">2013</span>;<span class="volume" tagx="volume" title="volume">5</span>:<span class="fpage" tagx="fpage" title="fpage">318</span>â€"<span class="lpage" tagx="lpage" title="lpage">27</span>.</span></li> <li tag="ref"><a name="CIT0056" /><span class="label" tagx="label" title="label">56</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ma</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bao</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Design, synthesis, biological evaluation and preliminary mechanism study of novel benzothiazole derivatives bearing indole-based moiety as potent antitumor agents</span>. <span class="source" tagx="source" title="source">Eur J Med Chem</span><span class="year" tagx="year" title="year">2015</span>;<span class="volume" tagx="volume" title="volume">96</span>:<span class="fpage" tagx="fpage" title="fpage">173</span>â€"<span class="lpage" tagx="lpage" title="lpage">86</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25874341">25874341</a></span></span></li> <li tag="ref"><a name="CIT0057" /><span class="label" tagx="label" title="label">57</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xie</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yan</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhu</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Benzothiazoles exhibit broad-spectrum antitumor activity: their potency, structure-activity and structure-metabolism relationships</span>. <span class="source" tagx="source" title="source">Eur J Med Chem</span><span class="year" tagx="year" title="year">2014</span>;<span class="volume" tagx="volume" title="volume">76</span>:<span class="fpage" tagx="fpage" title="fpage">67</span>â€"<span class="lpage" tagx="lpage" title="lpage">78</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/24576612">24576612</a></span></span></li> <li tag="ref"><a name="CIT0058" /><span class="label" tagx="label" title="label">58</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Uremis</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Uremis</span><span class="given-names" tagx="given-names" title="given-names">MM</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tolun</span><span class="given-names" tagx="given-names" title="given-names">IF</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis of 2-substituted benzothiazole derivatives and their inÂ vitro anticancer effects and antioxidant activities against pancreatic cancer cells</span>. <span class="source" tagx="source" title="source">Anticancer Res</span><span class="year" tagx="year" title="year">2017</span>;<span class="volume" tagx="volume" title="volume">37</span>:<span class="fpage" tagx="fpage" title="fpage">6381</span>â€"<span class="lpage" tagx="lpage" title="lpage">9</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29061823">29061823</a></span></span></li> <li tag="ref"><a name="CIT0059" /><span class="label" tagx="label" title="label">59</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cindric</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Peric</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kralj</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Antibacterial and antiproliferative activity of novel 2-benzimidazolyland 2-benzothiazolyl-substituted benzo[b]thieno-2-carboxamides</span>. <span class="source" tagx="source" title="source">Mol Divers</span><span class="year" tagx="year" title="year">2018</span>;<span class="volume" tagx="volume" title="volume">22</span>:<span class="fpage" tagx="fpage" title="fpage">637</span>â€"<span class="lpage" tagx="lpage" title="lpage">46</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29557543">29557543</a></span></span></li> <li tag="ref"><a name="CIT0060" /><span class="label" tagx="label" title="label">60</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nikolova Momekov</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bakalova</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Novel Ru(III) complexes with some benzothiazole derivatives: synthesis, physicochemical and pharmacological investigations</span>. <span class="source" tagx="source" title="source">Drug Res</span><span class="year" tagx="year" title="year">2015</span>;<span class="volume" tagx="volume" title="volume">65</span>:<span class="fpage" tagx="fpage" title="fpage">317</span>â€"<span class="lpage" tagx="lpage" title="lpage">22</span>.</span></li> <li tag="ref"><a name="CIT0061" /><span class="label" tagx="label" title="label">61</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yurttas</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cavusoglu</span><span class="given-names" tagx="given-names" title="given-names">KB</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sever</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ciftci</span><span class="given-names" tagx="given-names" title="given-names">AG.</span></span></span><span class="mixed-article-title" title="mixed-article-title">A preliminary investigation of anticanceractivity of novel benzothiazole derivatives against A549 lung carcinoma cell line</span>. <span class="source" tagx="source" title="source">Turk J Biochem</span><span class="year" tagx="year" title="year">2017</span>;<span class="volume" tagx="volume" title="volume">42</span>: <span class="fpage" tagx="fpage" title="fpage">217</span>â€"24.</span></li> <li tag="ref"><a name="CIT0062" /><span class="label" tagx="label" title="label">62</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Oanh</span><span class="given-names" tagx="given-names" title="given-names">KTD</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hai</span><span class="given-names" tagx="given-names" title="given-names">VH</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Park</span><span class="given-names" tagx="given-names" title="given-names">HS</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Benzothiazole-containing hydroxamic acids as histone deacetylase inhibitors and antitumor agents</span>. <span class="source" tagx="source" title="source">Bioorg Med Chem Lett</span><span class="year" tagx="year" title="year">2011</span>;<span class="volume" tagx="volume" title="volume">21</span>:<span class="fpage" tagx="fpage" title="fpage">7509</span>â€"<span class="lpage" tagx="lpage" title="lpage">12</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22036991">22036991</a></span></span></li> <li tag="ref"><a name="CIT0063" /><span class="label" tagx="label" title="label">63</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rodrigues</span><span class="given-names" tagx="given-names" title="given-names">RJ</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Charris</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Camacho</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title"><i>N-</i>Formyl-2-(5-nitrothiophen-2-yl)benzothiazole-6-carbohydrazide as a potential anti-tumour agent for prostate cancer in experimental studies</span>. <span class="source" tagx="source" title="source">J Pharm Pharmacol</span><span class="year" tagx="year" title="year">2013</span>;<span class="volume" tagx="volume" title="volume">65</span>:<span class="fpage" tagx="fpage" title="fpage">411</span>â€"<span class="lpage" tagx="lpage" title="lpage">22</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23356850">23356850</a></span></span></li> <li tag="ref"><a name="CIT0064" /><span class="label" tagx="label" title="label">64</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rao</span><span class="given-names" tagx="given-names" title="given-names">NS</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nagesh</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nayak</span><span class="given-names" tagx="given-names" title="given-names">LV</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Design and synthesis of DNA-intercalative naphthalimide- benzothiazole/cinnamide derivatives: cytotoxicity evaluation and topoisomerase-IIÎ± inhibition</span>. <span class="source" tagx="source" title="source">Med Chem Comm</span><span class="year" tagx="year" title="year">2019</span>;<span class="volume" tagx="volume" title="volume">10</span>:<span class="fpage" tagx="fpage" title="fpage">72</span>â€"<span class="lpage" tagx="lpage" title="lpage">9</span>.</span></li> <li tag="ref"><a name="CIT0065" /><span class="label" tagx="label" title="label">65</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rao</span><span class="given-names" tagx="given-names" title="given-names">SVA</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rao</span><span class="given-names" tagx="given-names" title="given-names">BB</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sunkari</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">2-Arylaminobenzothiazole-arylpropenone conjugates as tubulin polymerization inhibitors</span>. <span class="source" tagx="source" title="source">Med Chem Commun</span><span class="year" tagx="year" title="year">2017</span>;<span class="volume" tagx="volume" title="volume">8</span>:<span class="fpage" tagx="fpage" title="fpage">924</span>â€"<span class="lpage" tagx="lpage" title="lpage">41</span>.</span></li> <li tag="ref"><a name="CIT0066" /><span class="label" tagx="label" title="label">66</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Osmaniye</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Levent</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">ArdÄ±c</span><span class="given-names" tagx="given-names" title="given-names">MC</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis and anticancer activity of some novel benzothiazolethiazolidine derivatives</span>. <span class="source" tagx="source" title="source">Phosphorus Sulfur</span><span class="year" tagx="year" title="year">2018</span>;<span class="volume" tagx="volume" title="volume">193</span>:<span class="fpage" tagx="fpage" title="fpage">249</span>â€"<span class="lpage" tagx="lpage" title="lpage">56</span>.</span></li> <li tag="ref"><a name="CIT0067" /><span class="label" tagx="label" title="label">67</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Supuran</span><span class="given-names" tagx="given-names" title="given-names">CT.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Carbonic anhydrases: novel therapeutic applications for inhibitors and activators</span>. <span class="source" tagx="source" title="source">Nature Rev Drug Discov</span><span class="year" tagx="year" title="year">2008</span>;<span class="volume" tagx="volume" title="volume">7</span>:<span class="fpage" tagx="fpage" title="fpage">168</span>â€"<span class="lpage" tagx="lpage" title="lpage">81</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18167490">18167490</a></span></span></li> <li tag="ref"><a name="CIT0068" /><span class="label" tagx="label" title="label">68</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Supuran</span><span class="given-names" tagx="given-names" title="given-names">CT.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Structure and function of carbonic anhydrases</span>. <span class="source" tagx="source" title="source">Biochem J</span><span class="year" tagx="year" title="year">2016</span>;<span class="volume" tagx="volume" title="volume">473</span>:<span class="fpage" tagx="fpage" title="fpage">2023</span>â€"<span class="lpage" tagx="lpage" title="lpage">32</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27407171">27407171</a></span></span></li> <li tag="ref"><a name="CIT0069" /><span class="label" tagx="label" title="label">69</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Supuran</span><span class="given-names" tagx="given-names" title="given-names">CT.</span></span></span><span class="mixed-article-title" title="mixed-article-title">How many carbonic anhydrase inhibition mechanisms exist?</span><span class="source" tagx="source" title="source">J Enzyme Inhib Med Chem</span><span class="year" tagx="year" title="year">2016</span>;<span class="volume" tagx="volume" title="volume">31</span>:<span class="fpage" tagx="fpage" title="fpage">345</span>â€"<span class="lpage" tagx="lpage" title="lpage">60</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26619898">26619898</a></span></span></li> <li tag="ref"><a name="CIT0070" /><span class="label" tagx="label" title="label">70</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Neri</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Supuran</span><span class="given-names" tagx="given-names" title="given-names">CT.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Interfering with pH regulation in tumours as a therapeutic strategy</span>. <span class="source" tagx="source" title="source">Nat Rev Drug Discov</span><span class="year" tagx="year" title="year">2011</span>;<span class="volume" tagx="volume" title="volume">10</span>:<span class="fpage" tagx="fpage" title="fpage">767</span>â€"<span class="lpage" tagx="lpage" title="lpage">77</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21921921">21921921</a></span></span></li> <li tag="ref"><a name="CIT0071" /><span class="label" tagx="label" title="label">71</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Supuran</span><span class="given-names" tagx="given-names" title="given-names">CT.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Carbonic anhydrases and metabolism</span>. <span class="source" tagx="source" title="source">Metabolites</span><span class="year" tagx="year" title="year">2018</span>;<span class="volume" tagx="volume" title="volume">8</span>:<span class="fpage" tagx="fpage" title="fpage">pii:E25</span>.</span></li> <li tag="ref"><a name="CIT0072" /><span class="label" tagx="label" title="label">72</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Supuran</span><span class="given-names" tagx="given-names" title="given-names">CT.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Carbonic anhydrase inhibition and the management of hypoxic tumors</span>. <span class="source" tagx="source" title="source">Metabolites</span><span class="year" tagx="year" title="year">2017</span>;<span class="volume" tagx="volume" title="volume">7</span>:pii:E48.</span></li> <li tag="ref"><a name="CIT0073" /><span class="label" tagx="label" title="label">73</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Supuran</span><span class="given-names" tagx="given-names" title="given-names">CT.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Advances in structure-based drug discovery of carbonic anhydrase inhibitors</span>. <span class="source" tagx="source" title="source">Expert Opin Drug Discov</span><span class="year" tagx="year" title="year">2017</span>;<span class="volume" tagx="volume" title="volume">12</span>:<span class="fpage" tagx="fpage" title="fpage">61</span>â€"<span class="lpage" tagx="lpage" title="lpage">88</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27783541">27783541</a></span></span></li> <li tag="ref"><a name="CIT0074" /><span class="label" tagx="label" title="label">74</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Supuran</span><span class="given-names" tagx="given-names" title="given-names">CT.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Carbonic anhydrase inhibitors and their potential in a range of therapeutic areas</span>. <span class="source" tagx="source" title="source">Expert Opin Ther Pat</span><span class="year" tagx="year" title="year">2018</span>;<span class="volume" tagx="volume" title="volume">28</span>:<span class="fpage" tagx="fpage" title="fpage">709</span>â€"<span class="lpage" tagx="lpage" title="lpage">12</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30217119">30217119</a></span></span></li> <li tag="ref"><a name="CIT0075" /><span class="label" tagx="label" title="label">75</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Supuran</span><span class="given-names" tagx="given-names" title="given-names">CT.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Applications of carbonic anhydrases inhibitors in renal and central nervous system diseases</span>. <span class="source" tagx="source" title="source">Expert Opin Ther Pat</span><span class="year" tagx="year" title="year">2018</span>;<span class="volume" tagx="volume" title="volume">28</span>:<span class="fpage" tagx="fpage" title="fpage">713</span>â€"<span class="lpage" tagx="lpage" title="lpage">21</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30175635">30175635</a></span></span></li> <li tag="ref"><a name="CIT0076" /><span class="label" tagx="label" title="label">76</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nocentini</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Supuran</span><span class="given-names" tagx="given-names" title="given-names">CT.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery</span>. <span class="source" tagx="source" title="source">Expert Opin Drug Discov</span><span class="year" tagx="year" title="year">2019</span>;<span class="volume" tagx="volume" title="volume">14</span>:<span class="fpage" tagx="fpage" title="fpage">1175</span>â€"<span class="lpage" tagx="lpage" title="lpage">97</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31436118">31436118</a></span></span></li> <li tag="ref"><a name="CIT0077" /><span class="label" tagx="label" title="label">77</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">De Simone</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Supuran</span><span class="given-names" tagx="given-names" title="given-names">CT.</span></span></span><span class="mixed-article-title" title="mixed-article-title">(In)organic anions as carbonic anhydrase inhibitors</span>. <span class="source" tagx="source" title="source">J Inorg Biochem</span><span class="year" tagx="year" title="year">2012</span>;<span class="volume" tagx="volume" title="volume">111</span>:<span class="fpage" tagx="fpage" title="fpage">117</span>â€"<span class="lpage" tagx="lpage" title="lpage">29</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22192857">22192857</a></span></span></li> <li tag="ref"><a name="CIT0078" /><span class="label" tagx="label" title="label">78</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Supuran</span><span class="given-names" tagx="given-names" title="given-names">CT.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors</span>. <span class="source" tagx="source" title="source">Expert Opin Investig Drugs</span><span class="year" tagx="year" title="year">2018</span>;<span class="volume" tagx="volume" title="volume">27</span>:<span class="fpage" tagx="fpage" title="fpage">963</span>â€"<span class="lpage" tagx="lpage" title="lpage">70</span>.</span></li> <li tag="ref"><a name="CIT0079" /><span class="label" tagx="label" title="label">79</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tars</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Vullo</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kazaks</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Sulfocoumarins (1,2-benzoxathiine 2,2-dioxides): a class of potent and isoform-selective inhibitors of tumor-associated carbonic anhydrases</span>. <span class="source" tagx="source" title="source">J Med Chem</span><span class="year" tagx="year" title="year">2013</span>;<span class="volume" tagx="volume" title="volume">56</span>:<span class="fpage" tagx="fpage" title="fpage">293</span>â€"<span class="lpage" tagx="lpage" title="lpage">300</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23241068">23241068</a></span></span></li> <li tag="ref"><a name="CIT0080" /><span class="label" tagx="label" title="label">80</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">KÃ¶hler</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hillebrecht</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Schulze Wischeler</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Saccharin inhibits carbonic anhydrases: possible explanation for its unpleasant metallic aftertaste</span>. <span class="source" tagx="source" title="source">Angew Chem Int Ed Engl</span><span class="year" tagx="year" title="year">2007</span>;<span class="volume" tagx="volume" title="volume">46</span>:<span class="fpage" tagx="fpage" title="fpage">7697</span>â€"<span class="lpage" tagx="lpage" title="lpage">9</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17705204">17705204</a></span></span></li> <li tag="ref"><a name="CIT0081" /><span class="label" tagx="label" title="label">81</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Supuran</span><span class="given-names" tagx="given-names" title="given-names">CT</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ilies</span><span class="given-names" tagx="given-names" title="given-names">MA</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Scozzafava</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Carbonic anhydrase inhibitors. Part 29. Interaction of isozymes I, II and IV with benzolamide-like derivatives</span>. <span class="source" tagx="source" title="source">Eur J Med Chem</span><span class="year" tagx="year" title="year">1998</span>;<span class="volume" tagx="volume" title="volume">33</span>:<span class="fpage" tagx="fpage" title="fpage">739</span>â€"<span class="lpage" tagx="lpage" title="lpage">52</span>.</span></li> <li tag="ref"><a name="CIT0082" /><span class="label" tagx="label" title="label">82</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">SentÃ¼rk</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">GÃ¼lÃ§in</span><span class="given-names" tagx="given-names" title="given-names">I</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">DaÅŸtan</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Carbonic anhydrase inhibitors. Inhibition of human erythrocyte isozymes I and II with a series of antioxidant phenols</span>. <span class="source" tagx="source" title="source">Bioorg Med Chem</span><span class="year" tagx="year" title="year">2009</span>;<span class="volume" tagx="volume" title="volume">17</span>:<span class="fpage" tagx="fpage" title="fpage">3207</span>â€"<span class="lpage" tagx="lpage" title="lpage">11</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19231207">19231207</a></span></span></li> <li tag="ref"><a name="CIT0083" /><span class="label" tagx="label" title="label">83</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nocentini</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Supuran</span><span class="given-names" tagx="given-names" title="given-names">CT.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008â€"2018)</span>. <span class="source" tagx="source" title="source">Expert Opin Ther Pat</span><span class="year" tagx="year" title="year">2018</span>;<span class="volume" tagx="volume" title="volume">28</span>:<span class="fpage" tagx="fpage" title="fpage">729</span>â€"<span class="lpage" tagx="lpage" title="lpage">40</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30074415">30074415</a></span></span></li> <li tag="ref"><a name="CIT0084" /><span class="label" tagx="label" title="label">84</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Di Fiore</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pedone</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Antel</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Carbonic anhydrase inhibitors: the X-ray crystal structure of ethoxzolamide complexed to human isoform II reveals the importance of thr200 and gln92 for obtaining tight-binding inhibitors</span>. <span class="source" tagx="source" title="source">Bioorg Med Chem Lett</span><span class="year" tagx="year" title="year">2008</span>;<span class="volume" tagx="volume" title="volume">18</span>:<span class="fpage" tagx="fpage" title="fpage">2669</span>â€"<span class="lpage" tagx="lpage" title="lpage">74</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18359629">18359629</a></span></span></li> <li tag="ref"><a name="CIT0085" /><span class="label" tagx="label" title="label">85</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">SitaRam</span><span class="given-names" tagx="given-names" title="given-names">CM</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Khloya</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">4-Functionalized 1,3-diarylpyrazoles bearing 6-aminosulfonylbenzothiazole moiety as potent inhibitors of carbonic anhydrase isoforms hCA I, II, IX and XII</span>. <span class="source" tagx="source" title="source">Bioorg Med Chem</span><span class="year" tagx="year" title="year">2014</span>;<span class="volume" tagx="volume" title="volume">22</span>:<span class="fpage" tagx="fpage" title="fpage">6945</span>â€"<span class="lpage" tagx="lpage" title="lpage">52</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25456084">25456084</a></span></span></li> <li tag="ref"><a name="CIT0086" /><span class="label" tagx="label" title="label">86</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ibrahim</span><span class="given-names" tagx="given-names" title="given-names">DA</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lasheen</span><span class="given-names" tagx="given-names" title="given-names">DS</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zaky</span><span class="given-names" tagx="given-names" title="given-names">MY</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Design and synthesis of benzothiazole-6-sulfonamides acting as highly potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII</span>. <span class="source" tagx="source" title="source">Bioorg Med Chem</span><span class="year" tagx="year" title="year">2015</span>;<span class="volume" tagx="volume" title="volume">23</span>:<span class="fpage" tagx="fpage" title="fpage">4989</span>â€"<span class="lpage" tagx="lpage" title="lpage">99</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26048024">26048024</a></span></span></li> <li tag="ref"><a name="CIT0087" /><span class="label" tagx="label" title="label">87</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">KÃ¼Ã§Ã¼kbay</span><span class="given-names" tagx="given-names" title="given-names">FZ</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">BuÄŸday</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">KÃ¼Ã§Ã¼kbay</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis, characterization and carbonic anhydrase inhibitory activity of novel benzothiazole derivatives</span>. <span class="source" tagx="source" title="source">J Enzyme Inhib Med Chem</span><span class="year" tagx="year" title="year">2016</span>;<span class="volume" tagx="volume" title="volume">31</span>:<span class="fpage" tagx="fpage" title="fpage">1221</span>â€"<span class="lpage" tagx="lpage" title="lpage">5</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26598927">26598927</a></span></span></li> <li tag="ref"><a name="CIT0088" /><span class="label" tagx="label" title="label">88</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Petrou</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Geronikaki</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Terzi</span><span class="given-names" tagx="given-names" title="given-names">E</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Inhibition of carbonic anhydrase isoforms I, II, IX and XII with secondary sulfonamides incorporating benzothiazole scaffolds</span>. <span class="source" tagx="source" title="source">J Enzyme Inhib Med Chem</span><span class="year" tagx="year" title="year">2016</span>;<span class="volume" tagx="volume" title="volume">31</span>:<span class="fpage" tagx="fpage" title="fpage">1306</span>â€"<span class="lpage" tagx="lpage" title="lpage">11</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26745009">26745009</a></span></span></li> <li tag="ref"><a name="CIT0089" /><span class="label" tagx="label" title="label">89</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Payaz</span><span class="given-names" tagx="given-names" title="given-names">DÃœ</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">KÃ¼Ã§Ã¼kbay</span><span class="given-names" tagx="given-names" title="given-names">FZ</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">KÃ¼Ã§Ã¼kbay</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis carbonic anhydrase enzyme inhibition and antioxidant activity of novel benzothiazole derivatives incorporating glycine, methionine, alanine, and phenylalanine moieties</span>. <span class="source" tagx="source" title="source">J Enzyme Inhib Med Chem</span><span class="year" tagx="year" title="year">2019</span>;<span class="volume" tagx="volume" title="volume">34</span>:<span class="fpage" tagx="fpage" title="fpage">343</span>â€"<span class="lpage" tagx="lpage" title="lpage">9</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30734592">30734592</a></span></span></li> <li tag="ref"><a name="CIT0090" /><span class="label" tagx="label" title="label">90</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ammazzalorso</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Carradori</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Angeli</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Fibrate-based N-acylsulphonamides targeting carbonic anhydrases: synthesis, biochemical evaluation, and docking studies</span>. <span class="source" tagx="source" title="source">J Enzyme Inhib Med Chem</span><span class="year" tagx="year" title="year">2019</span>;<span class="volume" tagx="volume" title="volume">34</span>:<span class="fpage" tagx="fpage" title="fpage">1051</span>â€"<span class="lpage" tagx="lpage" title="lpage">61</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31074307">31074307</a></span></span></li> <li tag="ref"><a name="CIT0091" /><span class="label" tagx="label" title="label">91</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Abdoli</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Angeli</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bozdag</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis and carbonic anhydrase I, II, VII, and IX inhibition studies with a series of benzo[d]thiazole-5- and 6-sulfonamides</span>. <span class="source" tagx="source" title="source">J Enzyme Inhib Med Chem</span><span class="year" tagx="year" title="year">2017</span>;<span class="volume" tagx="volume" title="volume">32</span>:<span class="fpage" tagx="fpage" title="fpage">1071</span>â€"<span class="lpage" tagx="lpage" title="lpage">8</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28753093">28753093</a></span></span></li> <li tag="ref"><a name="CIT0092" /><span class="label" tagx="label" title="label">92</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Alterio</span><span class="given-names" tagx="given-names" title="given-names">V</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Esposito</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Monti</span><span class="given-names" tagx="given-names" title="given-names">SM</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Crystal structure of the human carbonic anhydrase II adduct with 1-(4-sulfamoylphenyl-ethyl)-2,4,6-triphenylpyridinium perchlorate, a membrane-impermeant, isoform selective inhibitor</span>. <span class="source" tagx="source" title="source">J Enzyme Inhib Med Chem</span><span class="year" tagx="year" title="year">2018</span>;<span class="volume" tagx="volume" title="volume">33</span>:<span class="fpage" tagx="fpage" title="fpage">151</span>â€"<span class="lpage" tagx="lpage" title="lpage">7</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29199489">29199489</a></span></span></li> <li tag="ref"><a name="CIT0093" /><span class="label" tagx="label" title="label">93</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Supuran</span><span class="given-names" tagx="given-names" title="given-names">CT.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Carbon-versus sulphur-based zinc binding groups for carbonic anhydrase inhibitors?</span><span class="source" tagx="source" title="source">J Enzyme Inhib Med Chem</span><span class="year" tagx="year" title="year">2018</span>;<span class="volume" tagx="volume" title="volume">33</span>:<span class="fpage" tagx="fpage" title="fpage">485</span>â€"<span class="lpage" tagx="lpage" title="lpage">95</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29390912">29390912</a></span></span></li> <li tag="ref"><a name="CIT0094" /><span class="label" tagx="label" title="label">94</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pustenko</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Stepanovs</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Å½alubovskis</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">3H-1,2-benzoxathiepine 2,2-dioxides: a new class of isoform-selective carbonic anhydrase inhibitors</span>. <span class="source" tagx="source" title="source">J Enzyme Inhib Med Chem</span><span class="year" tagx="year" title="year">2017</span>;<span class="volume" tagx="volume" title="volume">32</span>:<span class="fpage" tagx="fpage" title="fpage">767</span>â€"<span class="lpage" tagx="lpage" title="lpage">75</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28537099">28537099</a></span></span></li> <li tag="ref"><a name="CIT0095" /><span class="label" tagx="label" title="label">95</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ramya</span><span class="given-names" tagx="given-names" title="given-names">PVS</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Angapelly</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Angeli</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors</span>. <span class="source" tagx="source" title="source">J Enzyme Inhib Med Chem</span><span class="year" tagx="year" title="year">2017</span>;<span class="volume" tagx="volume" title="volume">32</span>:<span class="fpage" tagx="fpage" title="fpage">1274</span>â€"<span class="lpage" tagx="lpage" title="lpage">81</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28965419">28965419</a></span></span></li> <li tag="ref"><a name="CIT0096" /><span class="label" tagx="label" title="label">96</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Akocak</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lolak</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bua</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Supuran</span><span class="given-names" tagx="given-names" title="given-names">CT.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Discovery of novel 1,3-diaryltriazene sulfonamides as carbonic anhydrase I, II, VII, and IX inhibitors</span>. <span class="source" tagx="source" title="source">J Enzyme Inhib Med Chem</span><span class="year" tagx="year" title="year">2018</span>;<span class="volume" tagx="volume" title="volume">33</span>:<span class="fpage" tagx="fpage" title="fpage">1575</span>â€"<span class="lpage" tagx="lpage" title="lpage">80</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30296852">30296852</a></span></span></li> <li tag="ref"><a name="CIT0097" /><span class="label" tagx="label" title="label">97</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">El-Gazzar</span><span class="given-names" tagx="given-names" title="given-names">MG</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nafie</span><span class="given-names" tagx="given-names" title="given-names">NH</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nocentini</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Carbonic anhydrase inhibition with a series of novel benzenesulfonamide-triazole conjugates</span>. <span class="source" tagx="source" title="source">J Enzyme Inhib Med Chem</span><span class="year" tagx="year" title="year">2018</span>;<span class="volume" tagx="volume" title="volume">33</span>:<span class="fpage" tagx="fpage" title="fpage">1565</span>â€"<span class="lpage" tagx="lpage" title="lpage">74</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30274535">30274535</a></span></span></li> <li tag="ref"><a name="CIT0098" /><span class="label" tagx="label" title="label">98</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">D'Ascenzio</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Guglielmi</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Carradori</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Open saccharin-based secondary sulfonamides as potent and selective inhibitors of cancer-related carbonic anhydrase IX and XII isoforms</span>. <span class="source" tagx="source" title="source">J Enzyme Inhib Med Chem</span><span class="year" tagx="year" title="year">2017</span>;<span class="volume" tagx="volume" title="volume">32</span>:<span class="fpage" tagx="fpage" title="fpage">51</span>â€"<span class="lpage" tagx="lpage" title="lpage">9</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27784170">27784170</a></span></span></li> <li tag="ref"><a name="CIT0099" /><span class="label" tagx="label" title="label">99</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Scozzafava</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Menabuoni</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mincione</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Carbonic anhydrase inhibitors: perfluoroalkyl/aryl-substituted derivatives of aromatic/heterocyclic sulfonamides as topical intraocular pressure-lowering agents with prolonged duration of action</span>. <span class="source" tagx="source" title="source">J Med Chem</span><span class="year" tagx="year" title="year">2000</span>;<span class="volume" tagx="volume" title="volume">43</span>:<span class="fpage" tagx="fpage" title="fpage">4542</span>â€"<span class="lpage" tagx="lpage" title="lpage">51</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11087579">11087579</a></span></span></li> <li tag="ref"><a name="CIT0100" /><span class="label" tagx="label" title="label">100</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Scozzafava</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Briganti</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mincione</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Carbonic anhydrase inhibitors: synthesis of water-soluble, aminoacyl/dipeptidyl sulfonamides possessing long-lasting intraocular pressure-lowering properties via the topical route</span>. <span class="source" tagx="source" title="source">J Med Chem</span><span class="year" tagx="year" title="year">1999</span>;<span class="volume" tagx="volume" title="volume">42</span>:<span class="fpage" tagx="fpage" title="fpage">3690</span>â€"<span class="lpage" tagx="lpage" title="lpage">700</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/10479300">10479300</a></span></span></li> <li tag="ref"><a name="CIT0101" /><span class="label" tagx="label" title="label">101</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Supuran</span><span class="given-names" tagx="given-names" title="given-names">CT</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Clare</span><span class="given-names" tagx="given-names" title="given-names">BW.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Carbonic anhydrase inhibitors. Part 57. Quantum chemical QSAR of a group of 1,3,4-thiadiazole and 1,3,4-thiadiazoline disulfonamides with carbonic anhydrase inhibitory properties</span>. <span class="source" tagx="source" title="source">Eur J Med Chem</span><span class="year" tagx="year" title="year">1999</span>;<span class="volume" tagx="volume" title="volume">34</span>:<span class="fpage" tagx="fpage" title="fpage">41</span>â€"<span class="lpage" tagx="lpage" title="lpage">50</span>.</span></li> <li tag="ref"><a name="CIT0102" /><span class="label" tagx="label" title="label">102</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Supuran</span><span class="given-names" tagx="given-names" title="given-names">CT</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nicolae</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Popescu</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Carbonic anhydrase inhibitors. Part 35. Synthesis of Schiff bases derived from sulfanilamide and aromatic aldehydes: the first inhibitors with equally high affinity towards cytosolic and membrane-bound isozymes</span>. <span class="source" tagx="source" title="source">Eur J Med Chem</span><span class="year" tagx="year" title="year">1996</span>;<span class="volume" tagx="volume" title="volume">31</span>:<span class="fpage" tagx="fpage" title="fpage">431</span>â€"<span class="lpage" tagx="lpage" title="lpage">8</span>.</span></li> <li tag="ref"><a name="CIT0103" /><span class="label" tagx="label" title="label">103</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sarikaya</span><span class="given-names" tagx="given-names" title="given-names">SBÃ–</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Topal</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">ÅžentÃ¼rk</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">In vitro inhibition of Î±-carbonic anhydrase isozymes by some phenolic compounds</span>. <span class="source" tagx="source" title="source">Bioorg Med Chem Lett</span><span class="year" tagx="year" title="year">2011</span>;<span class="volume" tagx="volume" title="volume">21</span>:<span class="fpage" tagx="fpage" title="fpage">4259</span>â€"<span class="lpage" tagx="lpage" title="lpage">62</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21669522">21669522</a></span></span></li> </ul> </div> </div>  </body></html>